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1. 
GENERAL INTRODUCTlOc1. 
This thesis is an account of the study of some 
aspects of experimental malaria therapy carried out 
in an Army Research Team during the period July 1944 
to January 1946. -It covers investigations on the 
response to treatment of malaria cases seen under 
Field conditions in North Africa and Italy and deals 
with a continuation of similar work on anti -malarial 
compounds' conducted at a Military Hospital in England. 
Until the cessation of hostilities many of the find- 
ings in this work were restricted from publication 
owing to their bearing on military operations, a 
restriction for which there is now happily no need, 
so that expressions of opinion on the relative merits 
of different drugs may be freely given and supported 
by factual evidence hitherto not possible to disclose. 
A very great deal of research on the problem of 
malaria has been done in the last few years prompted 
e 
by the need for the United Nations to wage war in 
malarious countries at a time when the main World 
supply of Quinine was in enemy hands. This work, 
which received very high priority and official backing, 
was / 
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was carefully directed and co- ordinated in Britain 
and America by combined Committees of civilian.and 
Service Authorities who arranged for an organised 
approach to the problems presenting and for á mutual 
sharing of facilities for study as well as results. 
For reasons of security, little mention of this work 
has appeared in recent medical literature, but there 
can be few diseases which have been the subject of 
more organised study than malaria and few organisms 
that can have proved more wily and resistant antagon- 
ists than the cauaal Plasmodia. Scientists in 
university laboratories, synthetic chemists in the 
great drug manufacturing concerns, therapeutic trial 
teams in far -flung theatres of war and field control 
teams draining swamps and spraying D.D.T. from air- 
craft over jungles; all have played a part and made 
their contribution to the story of the united front 
against malaria and to the successes that have been 
achieved. It is indeed a solemn thought.for reflect- 
ion that nothing less than a world -wide conflict was 
.required for civilisation to support, with more than 
the customary financial pittance, medical research 
into the prevention and treatment of the disease which 
has been for long years the greatest single scourge 
of the human race. 
As an introduction to this thesis it will be 
fitting to outline for a few pages some of the more 
general/ 
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general considerations of the way in which malaria 
requirea to be overcome in the course of the recent 
World War. It is hoped, by sketching the main 
'features of the concerted attack on the disease, to 
place in its true perspective the part played by the 
work on therapeutic research which forms the subject 
matter of this thesis, and which will be seen to form 
one of many contributions to the effecting of the 
broad, organised plan. It will also serve to convey 
an idea of the encouraging progress that can result 
from international co- operation in medical research 
when applied to the relief of the commonest afflict- 
ions of mankind. 
The war in the Far East and in the Mediterranean 
presented three main problems in connection with 
malaria on the solution of which the successful con- 
duct of military operations in these theatres was 
largely dependent. The first of these concerned 
campaigns directed against the insect vector of malaria 
with anti- mosquito measures carried out on a scale 
never before attempted and covering vast. areas of 
tropical and sub -tropical countries abounding with 
malaria carrying Axlophelines. Through such areas 
large armies had to move, fight and be constantly 
supplied, and Malaria Control Units worked wonders 
in reducing the teeming mosquito population and showed 
how an entomologist with a bulldozer could achieve 
in/ 
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in a few days results undreamt of before the powers 
of modern warfare became directly interested in his 
efforts. In this battle against the mosquito in its 
natural habitat, chemical research produced insectici- 
des and repellents of ever increasing potency. 
culminating in the introduction of D.D.T., soon recog- 
nised as an agent of unparalleled effectiveness to 
be used with dramatic success. The fall story of 
D.D.T. in the War, of its use to stamp out a typhus 
epidemic in liberated Naples, and of it being fired 
in mortar shells to clear mosquitoes from the path of 
advancing troops in the jungles of Burma, will make 
fascinating reading when written and will prove 
another outstanding example of the possibilities of 
co- ordinated research when the need for results is 
pressing and the financial support forthcoming. 
The second main problem was how to effect. the 
optimum personal protection against malaria for the 
great numbers of men who had to keep moving through 
mosquito -ridden terrain in advance of the Control 
Units. These, the actual fighting men, had neither 
the chance or time to carry out the anti -mosquito 
measures such as could be enforced in the rear areas, 
and practical experience very soon taught that in the 
rapid entry or exit from a slit -trench, entanglement 
with a mosquito net was the last thing desired. 
Protection for these vital operational troops became 
thus/ 
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thus a question of prophylaxis by drugs and with over 
ninety per cent of the World's Quinine supplies in 
Japanese hands, reliance in this matter had to rest 
on the employment of the synthetic anti -malarial com- 
pounds. Two such preparations were in use before the 
War, both manufactured by a German firm, and their 
effects in the.treatment of active malaria infections 
had been studied by workers in many parts of the World 
The fact that they did not enjoy a wider pre -War 
popularity and their therapeutic actions had not been 
more closely investigated, was due perhaps to their 
formulae being among the more closely guarded secret's 
of the great German chemical industry, then being" 
geared up for War, and also to the reason that tropica 
clinicians could easily get ample quantities of Quinin 
an anti -malarial of proved value, enjoying a reputatio 
founded on some centuries of use in malaria treatment. 
Of the two synthetic preparations,:Atebrin, 
later manufactured under the British name Mepacrine 
was known to be effective in killing the asexual 
parasites of Malignant and Benign Tertian malaria, 
being of especial value in treating the former infect- 
ion as it greatly reduced both the incidence of sub- 
sequent relapses and of the dreaded complication, 
Blackwater Fever. It was known that it could be 
used if necessary as a substitute for Quinine in the 
routine therapy of active clinical malaria and as 
such/ 
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such was valuable in patients to whom the adminstrat- 
ion of Quinine was contra- indicated. It was realised 
that neither Atebrin or Quinine were very effective 
against the asexual forms of Quartan malaria, or in 
ridding the blood- stream of the gametocytes of any 
of the common Plasmodial infections. Comparatively 
little use on a wide scale, had been made, before the 
War, of Atebrin for drug -prophylaxis against malaria. 
Those who needed such protection had usually been 
given Quinine and there was a not unnatural hesitancy 
to employ, for this purpose, the prolonged adminstrat- 
ion of a new synthetic compound of which it was felt 
the remote pharmacological and possible toxic effects 
had not been adequately investigated. It must be 
!said therefore that the first real trial of Atebrin 
given as a prophylactic against malaria to thousands 
of other -Wise unprotected subjects, was forced upon 
the Armies of the United Nations by the Japanese 
advances of 1942. 
The second of the German synthetic anti -malarials 
was Plasmoquin, later made by British firms as Pamaquir. 
This drug was known mainly for its toxicity in malaria 
therapy and the whole attitude of many clinicians to- 
wards its use was clouded with suspicion arising from 
reports of its dangerous side -effects. It had thus 
gained little place in the routine treatment of malari 
being/ 
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being quite overshadowed by Quinine and Atebrin. 
Work of outstanding value on the action of Plasmoquin 
had been carried out in the Army in India by Sinton 
in the early nineteen thirties and it is more than 
interesting to see how after years of argument about 
the merits of this drug, the great searchlight of . 
War- stimulated malaria research has finally swung 
right round to become focussed on its properties and 
possibilities. Much more will be said of Pamaquin 
later in this thesis, but at this stage it will suffice 
to say that it was never seriously considered for use 
in the drug prophylaxis of malaria, being too toxic 
for prolonged administration and considered at that 
time to act only in destroying the sexual forms of 
parasites in human infections. 
An enormous amount of work was .done to determine 
the optimum use of Mepacrine as a prophylactic against 
malaria in the Armed Forces. Research Units were set 
up in Britain, America and Australia and the drug was 
given in varying doses over long periods of time to 
some thousands of Service and civilian volunteers. 
Investigations to show the rate of its absorption and 
excretion and the concentration of it attained in 
body fluids and tissues, were exhaustively conducted 
and the effects of taking Mapacrine under all manner 
of conditions such as physical stress and variations 
in climatic temperature, were also studied. After 
many/ 
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many forms of dosage had been tried, it was eventually 
decided that 0.1 gramme of Mepacrine taken daily pro- 
vided a fairly sure measure of protection against the 
development of an acute attack of malaria, and was a 
dosage that could be given to active troops for an 
indefinite time without danger Of toxic effects. 
Experimental evidence had shown, and practical exper- 
ience very soon proved, that in dealing with Benign 
Tertian and Quartan malaria, Mepacrine was only a 
suppressive drug which held an infection.in check 
in a sub -clinical state for as long as dosage was 
maintained. It was definitely not a true causal 
prophylactic in that it could not prevent the parasites 
from establishing themselves in the body following 
the bite of a malaria carrying mosquito. In such 
infected subjects the clinical manifestations of the 
disease became apparent after the cessation of 
suppressive Mepacrine dosage, presumably when the 
amount of drug in the circulation fell below the 
suppressive level. In dealing with Malignant Tertian 
malaria,-however, Mepacrine was a much more potent 
safeguard; for although it did not prevent the 
parasites from gaining access to the blood -stream, 
it was able to suppress them and to kill them off 
with such effect that the development of frank clinical 
malaria subsequent to the cessation of Mepacrine ther- 
apy was very much less likely to occur than with the 
other/ 
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other types of infection. Here then was a non -toxic 
drug which could offer unique protection against the 
dreaded scourge of M.T. malaria and could hold off 
the clinical effects of the less serious nuisance 
infection of B.T. malaria for as long as a steady 
dosage was maintained. 
The immense practical importance of Mepacrine 
in the conduct of the War became increasingly more 
obvious, for it was remembered only too well from 
the Gallipoli campaign of the 1914 -1918 War, the 
havoc that could be wrought by malaria in a Field 
Force inadequately protected against infection in 
hyper -endemic areas. The whole higher planning of 
offensive campaigns by the United Nations in the Far 
Eastern and Mediterranean theatres was found in 1942 
to 1943 to hinge largely on the availability of 
sufficient supplies of Mepacrine to provide protection 
for the troops engaged in operations during the malari- 
season. The campaign in Tunisia, Sicily and Southern 
Italy provided the first large scale trial of the 
efficiency of suppressive Mepacrine and showed conclus- 
ively that the success of such measures depended wholly 
on the strict observance of the daily Mepacrine rout- 
ine by all personnel. A widespread incidence of 
acute gastro -intestinal upset followed the taking of 
the first few tablets of Mepacrine in North Africa in 
April 1943 and did a great deal to shake the faith 
of/ 
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of the troops in this new much- boosted anti -malarial, 
so that many of them never tOok. it regularly there- 
after. The exact cause of this unfortunate occurr- 
ence was never fully discoverea but was probably 
associated with the fact that the dosage first tried 
was 0.2 gramme on three alternate days per week, a 
routine which was at once changed to 0.1 gramme 
daily. In Sicily where malaria casualties out- number 
ed the battle casualties in the ratio of 7 to 4, most 
cases of infection occurred amongst troops of the 
Eighth Army, tough, hard- boiled, desert warriors who 
rather scorned the new -fangled First Army idea of 
being ordered to take tablets against malaria and who 
realised too late that the steamy fever -ridden swamps 
of the Catania plain were a very different proposition 
from the hot, sandy wastes through which they had 
battled previously. Thére was evidence indeed that 
the 
the Germans were well aware of value of exposing the 
advancing Allies to malaria in their defensive retreat 
through Sicily and Italy; for apart from the purely 
strategic advantages employed in defending high ground 
overlooking a plain, they lost no opportunities to 
encourage malaria amongst their enemy by systematic- 
ally destroying the anti- mosquito measures that had 
been 44-important feature . of Italian Public Health 
policy through these areas. The flooding of the 
Pontine Marshes by the Germans in 1944 was a good 
example/ 
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example in this respect, for apart from the obvious 
effects of hindering land operations, the resultant 
encouragement to the mosquito population in this age - 
old stronghold of malaria, would have presented a 
serious problem to the maintenance of the troops in 
the Anzio beachhead if the final assault on Rome had 
not been successful before the malaria season was 
far advanced. 
Apart from the Mediterranean , mpaigns the value 
of Mepacrine, for the prophylaxis and suppression of 
malaria, was shown to be of paramount importance in 
the conduct of the War against Japan, both in the 
Pacific Islands and in the land offensive by the Four- 
teenth Army. In India and in West Africa, the great 
training areas for the Far Eastern War, this drug was 
used with outstanding success for the protection of 
thousands of troops, and it is indeed in a large 
measure due to.Mepacrine that victory in the East 
was achieved in a time far shorter than most of the 
World would have dared to forecast less than one 
year ago. 
The third great proble in dealing with malaria 
in war time was concerned with the treatment of cases 
who contracted the infection and where clinical mani- 
festations demanded admission as casualties.to medical 
units. It soon became apparent that in spite of the 
most strenuous measures for mosquito control and the 
most/ 
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most emphatic directives as to the vital need for 
strict Mepacrine discipline on the part of all personn- 
el, conditions at times were such that considerable 
numbers of malaria casualties would occur'and that the 
medical services had ever to be ready to cope with 
these on a large scale. It was found, for example, 
that malaria could manifest itself clinically in 
subjects who were taking regular suppressive Mepacrine, 
although the number of such cases was comparatively 
small. This matter was considered of sufficient 
importance however, to merit the attention of a special 
research unit which was sent to Italy to determine by 
estimating plasma Mepacrine levels, whether these men 
were really taking the drug and not absorbing it or 
whether, as was more often the case, the tablets had 
nbt been properly issued or had been conveniently 
lost before being swallowed. 
There were two factors which influenced the out- 
look on the question of the routine treatment of 
malaria. In the first place it was remembered how 
urgent was the need to conserve manpower, especially 
amongst the operational troops most exposed to infect- 
ion. This meant that medical units should employ a 
standard therapy course carefully devised to produce 
the optimum curative effect in the minimum time and 
thus enabling the patient to be fit to return to duty 
as soon as possible. Secondly there was need for the 
special/ 
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special treatment of cases who had suffered from multi - 
ple recurrences of malaria with resultant diminution 
in their general health and resistance. For these men, 
a slowly increasing number, who spent as much time in 
medical units as with their own units, some real 
attempt was demanded to eradicate the chronic malaria 
infection and to restore them to their former fitness. 
It was obvious that these two aspects of treat- 
ment required much careful, study before standard 
therapy courses could be laid down for routine admini- 
stration. That such courses needed to be standardis- 
ed in any one theatre of war became an accepted fact, 
in the Services where casualties had often to be 
evacuated from one medical unit to another after only 
short stays in transit, so that only by having a uni- 
form therapy regime could the essential continuity 
of treatment be obtained. Factors such as the main 
types of malaria infection likely to be encountered, 
the sensitivity of the local strains of-parasite to 
the action of different anti -malarial drugs, and the 
availability of supplies of these drugs, had all to 
be studied in each theatre before the important 
general directives on treatment could be drawn up. 
This work demanded the attention of whole -time research 
teams whose function was to investigate the relative 
merits of various trial therapy courses, assessing 
them by the clinical response of the patients, the 
detailed/ 
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detailed effects on the parasitaemia and the action 
of the drugs employed. Malaria therapeutic research 
teams were therefore formed in India, Test Africa and 
in the Central :; editerranean to study and to advise on 
the particular as Jec is of malaria treatmnt in ti : se 
theatres . Each team, while remaining a se; ar°atr 
entity primarily responsible to the local administrat- 
ion of the theatre, was associated w^wwith. the ,_alaria 
Committee of the Medical Research Council xhich 
arranged for the central co- ordination of resources 
and results. 
Having thus outlined, in a general way, some of 
the broader problems presented by malaria in the 
present War, it is convenient to divide this thesis 
into four main parts. The first part consists of a 
report and review of some of the studies in exper iment- 
al malaria therapy carried out by the Research Team 
formed and commanded by the author in North _ frics 
and Italy. It deals mainly with the use of Mepacrine 
in Benign and Malignant Tertian infections and sT+ oWs 
the investigations leading up to the design of a ther- 
apy course for routine use under field conditions. 
It deals also with the question of treat nt in cases 
of chronic relapsing malaria. The second part reports 
work carried out in England on cases of malaria return- 
ing from the Far East and contains an account of the 
detailed/ 
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detailed action of Pamaquin and the new anti -malarial 
compound Paludrine. A third part deals with a study 
of the staining of malaria parasites in thick blood 
films and a description of a new staining method is 
given. The fourth and final part consists of the 
main conclusions which it would appear could be 
justifiably drawn from the findings recorded. Each 
of the four parts is divided into appropriate sections 
where necessary. 
PART ONE. 
A REPORT OF WORK ON MALARIA THERAPEUTIC 
RESEARCH CARRIED OUT IN A MALARIA RESEARCH 
TEAM IN TIM MEDITERRANEAN THEATRE FROM 
JULY 1944 TO MAY 1945. 
18. 
PART ONE. 
A REPORT OF WORK ON MALARIA THERAPEUTIC RESEARCH 
CARRIED OUT IN A MALARIA RESEARCH TEAM IN THE 
MEDITERRANEAN THEATRE FROM JULY 1944 to MAY 1945. 
SECTION 1. 
Introduction Formation of Team and Prog.ramme of Work. 
The Malaria Research Team in C.M.F. was formed 
in June 1944 by the Consulting Physician A.F.H.Q. to 
carry out a Malaria Therapeutic Trial along the lines 
suggested by the Therapy Sub-committee of Malaria 
Committee of the Medical Research Council. 
The number of personnel available for this Team 
was at first Restricted by the man -power situation in 
O.H.F. to two British personnel, a Specialist Physician 
and a senior Laboratory Assistant, but a graded 
Infantryman was posted as a clerk during March 1945. 
Two Italian Co- operators, both with civilian and 
military experience of laboratory work, were attached 
to tha Team and provided reliable and valuable assist- 
ance throughout this work. 
The Team was designed for attachment to a General 
Hospital and work was begun at No.97 (Br.) General 
hospital in Bone, Algeria, early in July 1944. In 
September 1944 the Team was moved to Rome and attached 
to NO. 104 (Br.) General Hospital where it remained 
thereafter/ 
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thereafter. This change in location from North Africa 
to Central Italy was made necessary by the scarcity of 
Malaria cases in the Bone district, owing to the rapid 
clearance of Service personnel from the area and also 
to the effective Malaria prevention measures that were 
carried out at Bone during the Summer of 1944. The 
move implied disadvantages in that it broke the con- 
tinuity of the work of the Team for the month of 
September, and cases met with in the home area differed 
from the North African cases in being almost exclusively 
Benign Tertian infections. 
A total of 566 cases of Malaria were studied, this 
number being made up as follows: 
1. Active E.T. infections (a) Fresh 144 cases. 
(b) Relapse 277 cases. 
2. Active M.T. infections (a) Fresh 26 cases. 
(b) Relapse 2 cases. 
3. Active Quartan infections Fresh 1 case. 
4. Cases of Malaria having ) 
had multiple recurrences,) (a) B.T. 112 cases. 
admitted for investiga- ) 
tion while in a quiescent) (b) M.T. 4 cases. 
stage of the infection. ) 
It will be seen therefore, that this report deals 
mainly with active B.T. infections contracted in Italy. 
The results of treatment in the series of recurrent 
B.T. cases, and the findings in the very small but 
interesting group of North. African M.T. infections, are 
however considered worthy of mention and are also 
included in this report. 
18. 
SECTION 2. 
ME1HODS EMPLOYED IN THE THERAPY INVESTIGATION. 
1. General Clinical Procedure. 
As far as possible, the Malaria cases for treatment 
by the Research Team were admitted to one ward of the 
General Hospital. Changes in the nursing personnel 
took place during the investigation, but precautions 
were taken to see that Nursing Officers and orderlies 
looking after the cases were fully aware of the nature 
of the work being done, of the importance of taking 
accurate clinical records, and the need for ensuring 
that patients took the exact treatment prescribed. 
Detailed histories were taken in each case and 
particular attention was paid to each patient's frank 
description of the suppressive measures he had taken. 
Once the personal interest and co- operation of the 
patient had been obtained, it was found that details 
such as the average weekly suppressive Mepacrine dosage, 
use of mosquito nets etc., were quite freely given. 
The history included details of any previous 
attacks of Malaria and the patient's full account of 
the onset of the current attack. The question of any 
recent antecedent illness which could have played a 
part in precipitating the attack was enquired into and 
recorded. Only slide -positive, uncomplicated cases 
of Malaria were accepted for the purposes of this 
therapeutic/ 
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therapeutic trial. A physical examination was made of 
every patient and the presence or absence of splenic 
pain or enlargement was noted- 
New cases were seen on admission and brief clinical 
details were taken. The course of therapy to be given 
was then determined and cases were started. on treatment 
in strict rotation of courses and according to whether 
they were Nresh or Relapse infections. A treatment 
chart showing the drugs and exact dosage times was 
made out for each patient and was attached to the 
temperature chart at the bedside. Each dose was ad- 
ministered by a Nursing Officer and the co- operation of 
the patient was sought to ensure that the dosage regime 
was carried out as specified. Patients who had been 
treated on several occasions previously, with the 
standard treatment in use in the theatre, became quite 
interested when they found themselves on different 
forms of therapy and when the purpose of the investi- 
gation was explained to them. 
As far as possible all therapy courses were started 
at the same time of day. It became necessary half way 
through the investigation to change this starting time 
from morning to afternoon. This change was found to 
facilitate the existing ward and laboratory arrangement 
and it was felt that it in no way altered the interpre- 
tation of results. 
2./ 
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2. Laboratory Investigations. 
Parasite counts. The original intention was to 
record parasite counts done both in the morning and 
evening of each day of parasitaemia. This was done on 
the first 87 cases studied, but thereafter counts were 
done once daily in view of there being only one person 
to do the tedious work involved and also that it was 
apparent that the rate of diminution of parasites was 
such that adequate data could be obtained from counts 
done at intervals of 24 hours. 
Some time was spent in determining the best method 
of counting the parasites in the thick blood films 
taken before and during treatment. Several methods 
were tried and the results compared. It was finally 
decided to count the parasites seen in proportion to 
the number of leucocytes in thick evenly- spread films 
and to express the result in parasites per cubic milli- 
metre after estimation of the white -blood -cell count. 
It was found that by using films of more than average 
thickness, an even distribution of white cells was 
routinely obtained and with the staining method employ d 
there was little or no distortion of the leucocytes 
which could be easily counted against the parasites on 
a dehaemoglobinised background. In such thick films 
the distribution of parasites is much more even than 
in thin films where the parasitised cells tend to 
collect mostly at the ends and edges. In order to 
obtain/ 
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obtain an even distribution in thick films it is im- 
portant to prevent auto -agglutination of the red cells. 
The latter may be avoided by drying the freshly taken 
films in a warm oven or incubator. 
The staining method employed was a modification of 
Field's stain with a dilute Leishman counterstain. 
This method was elaborated after an investigation of 
the staining of malaria parasites in thick blood films 
and these experiments are fully described in Part Three 
of this thesis. The main advantage of the stain in 
this work was that by dehaemoglobinising very thick 
blood films, it was possible to count parasites as 
they diminished during treatment, even though they 
were present in very small numbers. 
Among other methods of counting parasites that 
were used to determine the accuracy of the above 
technique, was a modification of Sinton's chicken 
blood method which may be mentioned here. Sinton 
recommended that the parasitised blood be mixed with 
a known suspension of the nucleated chicken red blood 
corpuscles, against which the asexual parasites and 
gametocytes could be counted. This method is best 
suited for work under field conditions, enabling one 
worker to collect a great many prepared blood slides 
for counting at a later time. Apart from the dif- 
ficulties of obtaining supplies of chicken blood, the 
leucocyte/ 
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leucocyte method was preferred as repeated white cell 
counts were readily available under laboratory con- 
ditions. It was found that Sinton's method could be 
carried out using a known suspension of fixed and 
stained human red corpuscles prepared in the following 
manner. Red blood cells from oxalated blood were 
washed with normal saline and then transferred to Methyl 
Alcohol containing Methyl Blue, which both fixed and 
stained them a dark blue. As this dye is insoluble in 
watery solutions, it was possible to continue washing 
the stained cells in saline until all clumps had been 
eliminated and then to prepare a known dilution of a 
suspsnsion of the blue cells for admixture with the 
parasited blood. 
The stage of the parasite asexual cycle at which 
treatment was started, was noted in every case and 
therefore the daily parasite count recorded the numbers 
per cubic millimetre of both asexual forms and gameto- 
cytes. On an average, about 300 leucocytes were counted 
for each parasite count and the routine thick blood 
films employed were such that about 10 to 20 leucocytes 
were present in each oil immersion field. It will be 
described in a later section of this report how it was 
found of great interest to record the various stages 
of the parasite asexual cycle seen at intervals during 
treatment, thus making a qualitative or differential 




White blood cell counts were done on all patients 
before, during and at the end of treatment courses, so 
that details of the leucocytic reaction in the active 
Malaria infections studied are available in the general 
results. Haemoglobin estimations were made in every 
case at the start and finish of therapy, although the 
initial level was sometimes unduly high owing to the 
state of dehydration that was present in pyrexial cases 
on admission during hot weather. Red blood cell counts 
were done at the same times as the Haemoglobin estima- 
tions in the first 87 cases, but were subsequently 
discontinued owing to shortage of laboratory personnel. 
3. Follow-up of cases. 
An effort was made to secure a follow -up of cases 
over an adequate time as it was felt that in this way, 
more than in any other, was it possible to arrive at a 
true assessment of the value of the various treatment 
courses on trial. 
On discharge from hospital each patient was given 
a form which he was asked to retain and to produce it 
to a Medical Officer if he should be admitted to a 
medical unit with a relapse of Malaria. The form asked 
that if the relapse occurred in the area where the 
Research Team was working, the case should be readmitted 
to them for treatment and where the patient was seen 
and treated elsewhere, it was asked that details of 
the recurrence should be recorded and the form returned. 
The/ 
24. 
The co- operation of each patient was sought in ensuring 
this follow -up. 
It was considered that many of the above follow -up 
forms would be lost or go astray and accordingly a 
further form was posted to each patient 6 months from 
the end of his treatment. The patient was asked to 
supply details of any subsequent attacks during this 
period and to take the completed form to his Medical 
Officer or Orderly Room for posting back to the Research 
Team through the Official Mail. This method of follow - 
up proved most successful and it was felt that the 
time -interval of 6 months was of sufficient length to 
be of some value in assessing the curative value of 
the treatment courses employed. These forms were re- 
turned by many patients who had in the meantime left 
the theatre, but when there were no replies, an effort 
was made to trace the men by addressing a further form 
to them through the Records Office of their particular 
branch of the Service. By such means it was possible 
to obtain finally 6 month follow-up details in 78% of 
the total number of cases treated. 
4. The Therapj Courses. 
The Therapy Courses used on the active cases of 
Malaria were those laid down by the M.K.C. Malaria 
Committee, with the addition in 1944 of the standard 
treatment course in use in C.M.F. and B.N.A.F. during 
that season. The courses, which were employed in 
rotation were as follows:- 
25. 
A. For bresh infections: 
Course 1 Quinine gr 10 
Mepacrine 0.1 
Interval of 2 
Pamaquin 0.01 
T.I.D. for 3 days. 
gm. T.I.D. for 5 days. 
days (this was omitted in all 
but 2 cases). 
gm. T.I.D. for 3 days. 
Totals Quinine 90 gr. Mepacrine 1.5 gm. 
Pamaquin 0.09 gm. 
Course 2. Mepacrine 0.2 gm. Q.I.D. for 2 days. 
Mepacrine 0.1 gm. T.I.D. for 5 days. 
Total Mepacrine 3.1 gm. 
Course 3. Mepacrine 0.2 gm. T.I.D. for 1 day. 
Mepacrine 0.1 gm. T.I.D. for 6 days. 
Total Mepacrine 2.4 gm. 
Course 4. Mepacrine 0.2 gm. T.I.D. for 1 day. 
Mepacrine 0.1 gm. T.I.D. for 6 days. 
Pamaquin 0.01 gm. T.I.D. for 3 days. 
Totals Mepacrine 2.4 gm. Pamaquin 0.09 gm. 
Course 5. (Standard C.M.F. course 1944) . 
Quinine gr. 10 T.I.D. for 3 days. 
Mepacrine 0,2 gm. Q.I.D. for 2 days. 
Mepacrine 0.1 gm. T.I.D. for 3 days. 
Totals Quinine 90 gr. Mepacrine 2.5 gm. 
b. For Relapse infections. 
Course Rl Mepacrine 0.2 gm. Q.I.D. for 2 days. 
Mepacrine 0.1 gm. T.I.D. for 10 days. 
Total Mepacrine 4.6 gm. 
Course R2 Quinine gr. 10+ Pamaquin 0.01 gm. T.T.D. 
for 10 days. 
Totals Quinine 300 gr. Pamaquin 0.3 gm. 
C. For cases that relapsed after treatment with either 
Course R1 or R2' 
Course R3 Quinine Cìr 10 + 
Quinine gr 10 + 
with Pamaquin 0 
Pamaquin 0.01 gm. T. 
for 14 days. 
Pamaquin 0.01 gm. B. 




Totals Quinine 560 gr. Pamaquin 0.63 gms. 
27. 
SECTION 3. 
RESULTS OBTAINED IN THERAPEUTIC TRIAL. 
A. Numbers of Fresh Benign Tertian cases treated 
on each course. 
Course 1. 29 cases 
Course 2. 30 cases 
Course 3. 29 cases 
Course 4. 29 cases 
Course 5. 21 cases. 
1. Hate of disappearance of Asexual Parasites. 
Daily parasite counts enable the rate of fall -off 
of asexual parasites to be studied on a mathematical 
basis during treatment. 
Figure 1 shows the asexual parasite count plotted 
against the time in days while on therapy. In the 
construction of this graph, some adjustment of the 
initial and daily parasite figures was necessary to 
start all the cases at the sane average initial 
parasite count. The differences thereby made to the 
average daily counts were so slight that this purely 
mathematical correction was felt justifiable in view 
of the greatly increased ease with which the resultant 
graphs could be compared. 
Owing to the extremes of parasite count figures 
involved, a logarithmic scale has been employed in 
many of such graphs. 
As Figure 1 shows only the average rate of parasite 
disappearance on the different dosage regimes, the 
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28. 
are quoted to show the variations that can occur around 
these averages. 
'Asexual parasites are expressed in numbers per cu.mm. 
Course 1.- Quinine. 
Case Initial 24 48 72 95 
No. Asex.Count. hrs. hrs. hrs. hrs. 
102. 4000 Nil Nil Nil Nil 
317. 4200 330 110 Nil Nil 
441. 1100 1000 160 3 seen Nil 
Course 3.- Mepacrine - low initial dosa e. 
359. 4000 2500 Nil Nil Nil 
171. 2300 1260 Nil Nil Nil 
294. 1200 1300 220 2 seen Nil 
Course 2.- Mepacrine - hi h initial dosage. 
103. 600 Nil Nil Nil Nil 
293. 2500 200 Nil Nil Nil 
170. 3000 1600 2 seen Nil Nil 
2. Duration of Asexual Parasitaemia. 
Figure 2 shows the percentage number of cases who 
showed asexual parasites during the first few days of 
treatment and conveys better the finding that in the 
majority of cases the asexual parasites disappear from 
the peripheral blood in from 3 to 4 days from the 
commencement of treatment. 
Figure 3 shows this in the average duration of 
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3. Duration of Pyrexia. 
Figure 4 shows the average duration of pyrexia 
from the start of treatment in the Fresh B.T. infections 
treated on the therapy courses described. It will be 
seen that on the whole the cases became afebrile after 
about 36 hours of treatment which was before the 
asexual parasites had disappeared from the peripheral 
blood. 
4. Rate of disappearance of Uametocytes. 
Figure 5 shows the percentage number of cases who 
showed gametocytes during the first few days of treat- 
ment and Figure 6 shows the average time required for 
their disappearance on the various therapy courses 
It will be seen that on the whole the gametocytes 
are very much slower in disappearing than the asexual 
forms and in many cases continue to appear in fresh 
+showers after the asexual parasites have been cleared 
Ifrom the peripheral blood. 
Individual counts - of which three are quoted 
below as examples -- also show considerable variations 
from day to day. It was noticed that the large B.T. 
female gametocytes were more subject to daily varia- 
















































































































































































































































































































































































FIGURE 7.(page 30). 
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31. 
TABLE 1. AVERAUE INITIAL AND FINAL WHITE BLOOD CELL 
COUNTS OF B.T. FRESH CASES TREATED ON 
COURSES 1 - 5. 
Course 




W.B.C. per cu.mm. 
treatment. 
W.B.C.per ct. 
at end of 
treatment. 
1 (29 ) 
(Cases) 
11. 6,100. 7,800. 
2 (30 ) 
(Cases) 
7. 5,400. 7,300. 
3 (29 ) 
(Cases) 
7. 4,800 6 , 000 . 
4 (29 ) 
(Cases) 
10. 4,500 7,100. 
5 (21 ) 
(Cases) 
8. 5,550 8,000. 
It will be seen that the average initial white 
count on the 138 B.T. Fresh cases studied showed a 
slight leucopenia, which had returned to a normal 
average count at the end of each therapy course. 
The intermediate white counts during treatment are not 
shown, but it was found that the duration of the 
initial leucopenia was rarely more than four days 
irrespective of the treatment course employed. 
Examination. of over 30 stermal marrow smears from 
these cases showed that there was a slight maturation 
arrest at the late metamyelocyte and early non -segmented 
polymorph stage of the granular leucocyte precursors. 
This would account for the peripheral blood. picture in 
the stage of active parasitaemia. 
./ 
32. 
6. Haemoglobin percentae before and after treatment. 
Table 2 shows the average Haemoglobin percentages 
before and at the end of treatment in the 138 B.T. 
Fresh cases and shows also the length of the courses 
concerned. 
TABLE 2. AVERAGE INITIAL AND FINAL HAEMOGLOBIN 
PERCENTAGES OF B.T. FRESH CASES TREATED 
ON COURSES 1 - 5. 
Course 








at end of 
treatment. 
1 (29 ) 
(Oases) 
11. 97. 94. 
2 (30 ) 
(Cases) 
7. 97. 95. 
3 (29 ) 
(Cases) 
7. 100. 97. 
4 (29 ) 
(Cases) 
10. 100. 97. 
5 (21 ) 
(Cases) 
8. 99. 95. 
Ferrous Sulphate gr.6 in tablet form was given 
T.I.U. to all cases as a routine on the fourth day of 
treatment and thereafter.(jases on short therapy courses 
of 7 or 8 days had thus only 3 or 4 days of Iron before 
the final Haemoglobin level was estimated whereas 




It will be seen that on the whole there is little 
significant change in the Haemoglobin levels between 
the beginning and end of treatment in the 138 Fresh 
cases studied. 
biany of the cases in North Africa showed a fall in 
Haemoglobin during the first few days of treatment, 
coincident with their recovery from a state of dehydra- 
tion and haemoconcentration present on admission during 
the very hot weather. 
B. Numbers of Relapse Benin Tertian Cases Treated. 
Course R1 87 cases 
Course R2 - 94 cases 
Course R3 - 8 cases 
As Course R2 and R3 both start with the same dosage 
of Quinine plus Pamaquin for the first ten days, it is 
possible to consider cases treated on both courses as 
one group when studying the rate of disappearance of 
parasites and pyrexia, thus making 102 cases treated 
in this way. 
1. Rate of disappearance of Asexual Parasites. 
Figure 8 shows the rate of disappearance of 
asexual parasites on courses R1 and R2 + R3 by plotting 
the parasite counts done at twenty -four hour intervals 






























































































































































































































































































































































































































































































The following are examples of actual parasite 
counts and illustrate the rapidity of clearance of the 
initial parasitaemia that occurs in some cases on 
treatment. 
Asexual parasites are expressed in numbers per cu.mm. 
Course Rl. - Mepacrine. 
Case Initial 24 48 72 96 
ho. Asex.Count. hrs. hrs. hrs. hrs. 
259. 17000 480 Nil Nil Nil 
297. 8200 1700 Nil Nil Nil 
214. 3700 2500 210 Nil Nil 
Course R2. - Quinine plus Pamaquin. 
443. 17000 Nil Nil Nil Nil 
369. 5700 220 Nil Nil Nil 
392. 3600 2700 250 Nil Nil 
2. Duration of Asexual Parasites. 
Figure 9 shows the persistence of asexual parasites 
in terms of the percentage number of cases in which 
they were present on each day of treatment: Figure 10 
shows the average duration of asexual parasitaemia in 
the same 2 groups of cases. 
3. Duration of Pyrexia. 
Figure 11 shows the average duration of pyrexia 
from the start of treatment in the two groups of 
Relapse B.T. infections. 
4./ 
 
FIGURES 10,11,12.(pages 34,35). 
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4. Rate of disappearance of Gametocytes. 
Figure 12 indicates the persistence of gametocytes 
on Courses Ai and R2 + R3 as shown by the percentage 
number of cases with these forms present on the first 
few days of treatment. It will be seen that as in the 
Fresh infections, the gametocytes persist longer during 
treatment than the asexual forms and the same tendency 
for them to appear in showers during the first few days 
of therapy was observed. It is also evident from the 
results that the Quinine and Pamaquin combined treatment 
Í 
is more effective in clearing the gametocytes, than is 
the course with Mepacrine alone. 
¿xamples of Asexual .arasite and Gametocite counts i 
B.T.(Holapse) cases during; treatment. Counts in 
numbers /cu.mm. 
(1) Therapy Course R1 - Mepacrine. 
Initial 24 48 72 96 
count. hrs. hrs. hrs hrs. 
Asex. 6700 2000 Nil Nil Nil Nil Nil 
Uamet. 490 150 70 2 seen Nil Nil Nil Nil 









Asex. 4000 4200 480 Nil Nil Nil Nil Nil 
Gamet. 400 400 220 280 160 2 seen Nil Nil 
(2) Therapy Course R2 - Quinine + Pamaquin. Cases 211 and 347. 
Asex. 7500 920 Nil Nil Nil Nil Nil Nil 
Uamet. 420 240 70 1 seen Nil Nil Nil Nil 
Asex. 1960 120 Nil Nil Nil Nil Nil Nil 
ùámet. 240 200 3 seen 1 seen Nil Nil Nil Nil 
Figure/ 
FIGURES 13,14.(page 36). 
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36. 
Figure 13 shows the rate of disappearance of 
gametocytes on Courses R1 and R2 ± R3 in graphic form 
with the average daily gametocyte count for the first 
six days of treatment. 
Figure 14 shows of average duration in days of 
gametocytes in the same groups of cases. 
5. The average white blood -cell counts at the start 
and finish of Courses R1 and R2 are shown in Table 3. 
As in the Fresh infections, a very slight initial 
leucopenia was present in the 181 Relapse cases studied 
but at the end of the 10 or 12 day courses the white 
count had returned to within normal limits, the change 
taking place during the first 3 or 4 days of treatment. 
TABLE 3. AVERAGE INITIAL AND FINAL WHITE BLOOD CELL 
COUNTS OF B.T. RELAPSE CASES TREATED ON 









W.B.C. per cu.m] 
at end of treat 
ment. 
Rl (87 ) 
(Cases) 








6. Haemoglobin percentages in Relapse cases treated 
on Courses R1 and R2. 
The average initial and final Haemoglobin percent- 
ages in cases treated on these courses are shown in 
Table/ 
37. 
Table 4. As in the Fresh infections, there would appear 
to be little significant change in these levels and the 
average figures for the whole group of 181 Relapse 
cases show no evidence of anaemia consequent upon the 
recurrent nature of the infection. It would not seem 
that in this series, the administration of Pamaquin 
0.01 gm T.I.D. for ten days had any adverse effect on 
the Haemoglobin level. 
TABLE 4. AVERAGE INITIAL AND FINAL HAEMOGLOBIN 
PERCENTAGES OF B.T. RELAPSE CASES TREATED 










at end of 
treatment. 
R1 (87 ) 
(Cases) 
12 93. 98. 
R2 (94 ) 
(Cases) 
10 95. 95. 
Follow -up of Fresh and Relapse B.T. 
went in the Active Phase. 
1. Fresh B.T. infections. 
Cases after Treat, 
It was possible to follow -up 120 cases who were 
treated on therapy courses i to 5. Under the follow -up 
system/ 
38. 
system adopted, cases who relapsed within a relatively 
short time of leaving hospital were notified by other 
medical units or were readmitted for treatment with 
Course Ri or R2. All cases were sent follow -up forms 
six months after completing treatment for their last 
known attack and the nil returns of this type constituté 
a record of six months freedom from active Malaria 
following the therapy course on trial. The results of 
this follow -up of B.T. Fresh cases are shown in Table 5. 
TABLE 5. 
Course. 1. 2. 3. 4. 5 
No. treated. 29 30 29 29 21 
No. followed 
for 6 months. 
26 23 27 25 19 
RELAPSE. 5 9 7 :3 5 
NO RELAPSE. 21 14 20 22 14 
The numbers of cases treated and followed -up are 
too small to allow any conclusions to be drawn regard- 
ing the respective values of the 5 therapy courses 
concerned. Application of the Chi -square Test to 
these figures shows that according to the generally 
accepted level of significance of 1 in 20, there are 
no really significant differences between the follow -4 
results obtained on any of these courses. This 
negative/ 
39. 
negative finding is in itself of soma interest, although 
the same courses tried on much larger series of cases 
might well have shown significant differences in re- 
lapse ratos. It seems permissible however, to draw 
attention to the two following points which are shown 
in the actual figures of the limited results given in 
Table 5. 
Courses 2, 3 and 5, which contain no Pamaquin, 
show a higher relapse rate than Courses 1 and 4 which 
included three days of Pamaquin at the end of the 
treatment. 
The heavy 'Iepacrine course No.2, giving 3.1 gm 
in 7 days, would appear to be no more effective in 
preventing relapses than Course 3 which gave only 2.4 
gm. in the same time. 
2. Relapse B.T. infections. 
Follow-up details were obtained in 139 cases of 
B.T. Relapse infections treated on Courses R1(Mepacrine) 
and R2 (Quinine + Pamaquin). These results are shown 
in Table 6. 
TABLE 6. 
Course. Rl. R2. 
No. treated. 87 94 
No. followed 
for 6 months. 
67 72 
RELAPSE. 24 10 
NO RELAPSE. 43 62 
40. 
In this follow -up the numbers of cases treated 
are much larger than in Table 5 and statistical analysis 
of the results by the Chi -square Test shows a signifi- 
cant difference between the two courses, favouring the 
10 day Quinine + Pamaquin treatment as being more 
effective than the 12 day Mepacrine course in the 
prevention of further malaria relapses. (Chi squared = 
7.88. Probability = less than 0.01. Yates' correction 
for Continuity applied). 
In the patients who relapsed after Course R2, it 
was found that the recurrences occurred within an 
average of less than one month from the completion of 
treatment. Following the Mepacrine course R1, the 
average time before recurrence in the 24 patients who 
relapsed was nearly three months. This comparison 
suggests that an erroneous impression as to the 
efficacy of a treatment course might arise if too 
short a follow -up period were adopted. It also raises 
the interesting possibility of there being an essential 
difference in the mode of action of Quinine + Pamaquin 
and Mepacrine in attacking the more resistant parasite 
stages of B.T. malaria in cases who have already had 
more than one clinical attack. 
41. 
SECTION 4. 
PART A. RESULTS OF TREATMENT IN MALIGNANT TERTIAN CASES. 
As previously stated, the number of cases of M.T. 
Malaria available for study, was disappointingly small, 
being less than a total of 30 cases. Of this number, 
the majority were Fresh infections contracted in the 
Bone area in North Africa and they were treated on 
the same therapy courses 1 to 5 in rotation as were 
the Fresh B.T. infections. Parasite counts done at 
12 hourly intervals, morning and evening were obtained 
for most of these cases, and whereas the small number 
makes them of no certain statistical value, they are 
included in this report as a matter of interest and 
as they constitute a record of M.T. malaria parasite 
counts for cubic millimetre under the influence of 
therapeutic drugs. 
As in the case of the Fresh B.T. infections, it 
is convenient to group together cases on Courses i and 
5 as being treated with Quinine for the first 3 days, 
and Courses 3 and 4 which started treatment with low 
initial mepacrine dosage, as distinct from Course 2 
where heavier mepacrine dosage was given. Only the 
asexual parasite counts are given here, as gametocyte 
counts on so few cases could have little value. The 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the main points that it would appear justifiable to 
make from the study of this small series : - 
1. There tends to be a great variation in the asexual 
parasite count with high and low counts following 
one another in a rough periodic formation. This is 
shown especially in the casea marked with an asterisk 
which demonstrate also how a low initial count may 
suddenly increase with great rapidity. 
In several cases it was noticed that the highest 
parasite counts corresponded exactly with the 
highest peak of temperature. Thus in cases having 
a continuous temperature, the rise of one or two 
extra degrees every 48 hours was associated with a 
striking soaring up of the numbers of trophozoites 
in the blood stream and such high counts subsided 
as quickly once the peak of temperature was passed. 
From this it would seem that the best time for the 
diagnostic demonstration of the parasites in blood 
films would be at the extreme peak of the pyrexia, 
when their number may be disproportionately high 
in relation to the temperature. 
These observations might also suggest that the 
clinical peak of pyrexia would be the optimum time 
for the start of treatment with intravenous Quinine 
or intramuscular mepacrine. At that time the 
infection is represented by a great number of 
circulating/ 
43. 
circulating young ring forms and there would seem 
to be much less risk of causing a sudden liberation 
of toxic products, than when powerful drugs are 
injected to act on the schizonts which in M.T. 
Malaria lurk in the capillaries of the visceral 
organs. 
2. The Mepacrine courses (2, 3 and 4) allowed the 
asexual parasitaemia to persist for 72 hours in 
3 out of 15 cases, and 1 case on low Mepacrine 
dosage continued to show trophozoites for 132 
hours from the start of treatment. In the 9 cases 
treated with Quinine only 1 case showed a very 
scanty parasitaemia 60 hours from the start of 
treatment. The clinical impression was formed 
that the Quinine was more effective than Mepacrine 
in the initial control of pyrexia and general 
symptoms. 
Follow-up of M.T. Fresh infections treated on Courses 
1 to 5. 
Of the 24 cases treated, 16 were followed up for 
six months. 
Of this number only 2 had relapsed and both had 
been readmitted for treatment by the Team. 
The 2 cases that relapsed had both been treated 
originally on Course 1, which will be noted, contained 
less Mepacrine (Total 1.5 gm) than any of the other 
courses. 
44. 
PART B. STERNAL MARROW EXAMINATIONS ON CASES OF B.T. 
AND M.T. MALARIA. 
A study was made of smears of sternal marrow 
obtained from 52 cases of B.T. and M.T. infections 
treated in North Africa and Italy. The observations 
made in this small but interesting series may be 
summarised briefly as follows: - 
1. It was not found possible to demonstrate asexual 
parasites of either B.T. or M.T. Malaria in the 
sternal marrow when they were not demonstrable in 
thick films of the peripheral blood. When present 
in the marrow blood, the estimated parasite count 
was not found to exceed that in the peripheral 
blood. 
2. The gametocytes of M.T. Malaria were found amongst 
sheets of marrow cells in several Fresh cases on 
the third day of treatment; that is about 3 days 
before they appeared in the peripheral blood. 
Many of these marrow forms were rounded and im- 
mature, and it seems possible that in M.T. Malaria 
the gametocytes may be formed among the cells of 
the reticulo- endothelial system, of which the 
sternal marrow is a representative sample. 
3. The initial leucopenia so commonly present in 
active Malaria infections is shown in sternal 
marrow/ 
45. 
marrow smears to result from a maturation arrest 
at the metamyelocyte stage of the granular white 
cell precursors. It would appear to be a temporary 
toxic suppression of polymorph formation and dis- 
appears quickly when specific anti-malarial therapy 
is instituted. 
4. A most careful search was made in all the marrow 
smears for any non - pigmented form of parasite that 
might represent an extra- erythrocytic phase, but 
nothing convincing was observed. Several cases 
showed small rounded extracellular bodies with 
red granules set in a pale blue cytoplasm and 
which at first appeared rather like parasites. 
for want of a more apt description they were called 
"curious bodies" and their presence or absence was 
recorded in all the cases studied. It seemed from 
this work that these structures bore no relation 
to the stages of the infection in the peripheral 
blood and they were observed also in marrow smears 
from patients who had no history of Malaria. It 
was concluded that the "curious bodies" represented 
only rounded granular cytoplasmic debris from 
damagea myelocytes and were thus artefacts. It 
seemed that the finding of similar bodies was being 
studied by some Italian civilian workers, and photo- 
micrographs/ 
46. 
photomicrographs of such structures might appear to 
have many of the characteristics that may be looked 





A STUDY OF THE EFFECTS OF THE 
ANTI -MALARIAL DRUGS ON THE ASEXUAL 
PARASITES OF BENIGN TERTIAN MALARIA. 
During the daily examination of blood films 
from patients under treatment for B.T. infections, 
it was noticed that in some cases, disappearance of 
the asexual parasites occurred more rapidly than in 
others. It was thought worth while to pursue this 
study and to see what evidence could be found as to 
the more detailed action of the anti -malarial drugs 
employed. With this object in view, it was decided 
to record not only the actual number of asexual 
parasites per cubic millimetre in the films, but to 
note also the stages of development of the parasite 
asexual cycle represented by each count. 
Owing to the somewhat cumbersome terminology 
involved in describing the various stages of the 
parasite/ 
48. 
parasite asexual cycle, it was found convenient to 
introduce an abbreviated notation to indicate 10 
distinct stages of the cycle which could be recognis- 
ed microscopically. This notation sub- divided the 
48 hour cycle into 6 stages of trophozoites, (T 1 to 
T 6), 3 stages of schizonts, (S 1 to S 3), and a 
iderocyte, (M) . 
In order to make quite clear the microscopical 
appearances implied by each symbol in this notation, 
the fallowing few pages are devoted to a series of 
diagrams and descriptions of the various parasite 
stages. The sketches were made from Leishman- 
staixied thin blood film preparations of the common 
strain of Italian Benign Tertian parasite and the 
approximate time of appearance and duration of each 
stage in the 48 hour cycle is indicated. To 
complete this series of parasite diagrams, drawings 
and descriptions of gametocytes are also included. 
49 . 
T 1. Very young trophozoites found just after 
the clinical paroxysm and often accompanied by a few 
late schizonts. Two forms are shown, (a) a young 
parasite that has just entered a fresh red cell after 
sporulation, and (b), the parasite seen a few hours 
later as an early ring trophozoite. At this stage, 
the red cell has contracted with a well -marked fim- 
briated outline and the first signs of Schuffnerts 
dots have formed from changes in the cell envelope, 
The dots are seen as faint, short, curved lines in 
the parasitised red cell. 
Approximate duration of T 1, 0 to 6 hours. 
50. 
i 
T 2. Ring -form trophozoites, morphologically 
similar to stage T 1 but growing slightly larger and 
beginning to show early amoeboid activity. Two forms 
(a) a young T 2 seen as a definite ring, 
and (b), a later.T 2 in which the parasite has grown, 
has rougher cytoplasm, and has wriggled so that the 
appearance of the vacuole is lost. The red cell has 
a smooth outline and begins to enlarge during the T 2 
stage as a result of parasite activity. The Schuff- 
ner's dots become well- marked as small, rod -like flecks 
in the cell envelope. 
. Approximate duration of T 2, 6 to 10 hours. 
51. 
T 3. A growing amoe- 
boid trophozoite. The 
parasite has become 
actively amoeboid and 
its coarse cytoplasm 
is often spread abouti 
its red cell. Pigment 
has begun to collect 
at one end of the 
parasite. The red cell 
is by now much enlarged and Schuffner's dots are numer- 
ous, prominent and less rod -like than previously. 
Approximate duration of T 3. 10 to 20 hours. 
T 4. An almost fully- 
grown amoeboid trophozoite 
in which the amoeboid 
activity has begun to 
slow down so that the 
cytoplasm becomes con- 
tinuous againand vac - 
uolation- often multiple- 
reappears. Pigment is 
seen scattered through- 
out the cytoplasm. 






T 5. A fully grown 
amoeboid trophoizoite, 
now only sluggishly 
amoeboid. Pigment is 
accumulating through- 
out the cytoplasm, 
making it a greyish - 
blue colour. The 
chromatin nucleus be- 
comes- larger and less 
dense. 
Approximate duration of T 5, 26 to 30 hours. 
T 6. A dividing 
trophozoite. The.chro- 
matin nucleus splits 
into many fine partic- 
les preparatory to 
segmentation. The 
cytoplasm is vacuolated 
and is a grey -brown 
blue colour, due to 
diffuse pigment. The 
whole parasite is more rounded, as the amoeboid activ- 
ity has ceased. Schuffneris dots can still be seen 
in the envelope of the red cell. 
Approximate duration of T 6, 30 to 36 hours. 
5:3, 
S 1. A young 
schizont. Two to 
four distinct chromat- 
in nuclei can be seen, 
and there are usually 
several small vacuoles 
in the cytoplasm which 
stains a clear blue as 
the brownish pigment 
is collecting together 
at one spot. The 
parasite and red cell have become slightly smaller. 
Approximate duration of S 1, 36 to 42 hours. 
S 2. A mid -stage 
schizont with four to 
eight chromatin nuclei, 
and in which further 
nuclear sub -division is 
occurring. The vacuol- 
es in the blue cyto- 
plasm have disappeared 
at this stage and a 
collection of dark - 
brown pigment can be seen. 
, Approximate duration of S 2, 42 to 46 hours. 
54. 
S 3. A late 
schizont with eight 
to twelve chromatin 
nuclei and with the 
cytoplasm starting 
to divide up around 
each nucleus. 
Approximate duration of S 3, 46 to 474 hours. 
M. A complete 
merocyte with sixteen 
chromatin nuclei and 
attached cytoplasmic 
fragments(merozoites). 
A dark brown mass of 
malarial pigment can 
be seen amongst the 
merozoites and the 
shadowy outline of 
the red cell with faint 
ible. 
Schuffner's dots is just vis- 
This stage is very fragile and lasts only a 
matter of minutes before bursting to liberate a new 
generation of young trophozoites. 
Approximate duration of M, 474 to 48 hours. 
55. 
Young and Growing Male Gametocytes. 
Young and Growing Female Gametocytes. 
Very youizg male and female gametocytes are 
presumed to be formed from merozoites. Two forms 
are seen, one with a central chromatin nucleus and 
which/ 
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which probably developes into a male gametocyte, and 
the other with an eccentric nucleus which is probably 
the early female gametocyte. 
The growing gametocytes are quite clearly dis- 
tinguishable from one another. The male form is 
rounded in outline, has greenish -brown cytoplasm with 
golden -brown pigment scattered in it and the parti- 
culate chromatin nucleus is central and surrounded by 
a clear space. The developing female gametocyte is 
more oval in outline, has deep blue cytoplasm with 
scattered dark -brown pigment and the chromatin of the 
nucleus is situated in a clear space at one end of 
the parasite. The developing gametocytes do not 
cause so much enlargement of the red cell as the 
asexual forms, as they show little amoeboid activity. 
Schuffnerfs dots occur, but are pale in colour. 
Mature male and female 
gametocytes:- see next page. 
57. 
The mature female 
gametocyte, (macro - 
gamete), is larger 
than the male gameto- 
cyte and is the larg- 
est form of malaria 
parasite found on 
blood examination, 
being bigger than any 
of the asexual stages. 
It is an oval parasite with purple -blue cytoplasm 
containing scattered dark -brown gpanular pigment. The 
chromatin nucleus is more concentrated than that of 
the male gametocyte and is situated at the periphery 
of the cell ina clear halo. - Schùffner's dots are 
present in the envelope of the distended red cell. 
The mature male 
gametocyte ,(micro - 
gamete), has pale 
greenish -blue cyto- 
plasm with golden - 
brown, rod -like pig- 
ment scattered through 
out it. The.nucleus 
is.large and central 




THE MAIN MICROSCOPICAL APPEARANCES SEEN IN THE B.T. 
ASEXUAL PARASITES DURING TREATMENT WITH MEPACRINE, 
PA1AQUIN AND QUININE, WERE RECORDED AS FOLLOWS. 
A. MMepacrine. 
Three effects have been consistently noted due to 
Mepacrine. The first and most striking of these is 
the bunching up and rounding off of the trophozoite 
resulting from the disappearance of the vacuole and 
a collapse of the amoeboid ring form. 
The second effect noted is an alteration in the 
pigment normally found in the asexual parasites. This 
would seem to result from the collecting together and 
extrusion of the pigment and under these circumstances 
the parasite cytoplasm stains a clear blue colour in 
contrast to the usual pale grey blue staining. 
Once the above two effects begin to show themselves 
in the developing trophozoites, the latter tend to be 
retarded in their developmental process. 
The third abnormal appearance seen with Mepacrine 
action is usually found comparatively late in treatment 
when the parasites appear to be ragged and bedraggled 
in outline and seem to be on the point of cytoplasmic 
disruption. 
B. Pamaquin. 
This drug was found to have an action on asexual 
parasites/ 
59. 
parasites very similar to that of Mepacrine, although 
it was much slower in producing the first visible 
microscopic changes in the parasite cell. This finding¡ 
when reported, caused some surprise amongst authorities 
(P.O. Shute et al.) who understood that Pamaquin was a 
powerful gametocide but produced little effect on the 
asexual forms of B.T. malaria. It was therefore 
decided to study this action of Pamaquin in greater 
detail at a later date and some of the findings in this 
investigation are reported in Part Two of this thesis 
which deals with work done on cases of B.T. malaria 
treated in Britain in the Autumn of 1945. 
C. Quinine. 
No visible changes were noted in the morphology 
of the asexual parasites during the action of Quinine, 
though those found late in treatment often presented 
a pale appearance and had a ragged cell outline as with 
Mepacrine. Quinine also was observed to inhibit the 
development of the parasites. 
In addition to the general slowing effect of all 
the three drugs on the whole asexual developmental 
cycle, it was noticed that when cases were started on 
treatment during the middle trophozoite stage, there 
were occasions when the parasites ceased to develop 
beyond the stage of chromatin division though on other 
occasions/ 
60 . 
occasions development continued with the production of 
some young trophozoites. The retarded development forms 
corresponded to the T6 stage on the notation adopted, 
and were found to persist for 12 to 24 hours after 
6'. 
other parasites had undergone schizogomy and had become 
young trophozoites. While there is no direct evidence 
to show that the T6 stage is more specifically arrested 
than other stages of the cycle, it is interesting to 
note that it represents the largest form of the 
trophozoite series and by virtue of its size alone, 
may be less susceptible to phagocytosis than the smaller, 
younger forms. It was thought that it would be a 
matter of great interest to reproduce the conditions 
governing this delay by giving drugs in such a manner 
as to encourage the maximum formation of these retarded 
T6 parasites. This and the allied investigations 
described below, were carried out only with Mepacrine. 
In the first experiment, 2 cases having a 
moderately heavy infection with tertian fever, were 
loft untreated until the parasites had developed to the 
T6 stage. They were then given an intramuscular in- 
jection of Mepacrine 0.2 gm. (Atebrin Dihydrochloride - 
Winthrop.) and no further treatment was given during 
the following 24 hours. Blood films were examined 24 
hours after the injection when it was found that instead 
of the expected "hold -up ", a striking disappearance of 
the/ 
61. 
the asexual parasites had occurred. In one case (No. 
246) the initial count of 14,000 per cubic mm. had 
fallen to 50 per cubic mm. in 24 hours, and in the 
second case (No.249) all the parasites which were 
present initially - 4,200 per cubic mm. had disappeared 
within the 24 hours. Such a rapid clearance of para- 
sites from the peripheral blood had no comparison with 
the effects of any of the ordinary treatment courses 
observed. For the time being, attempts to cause a 
block or delay at the stage of division were abandoned 
in favour of this more interesting effect which had 
come to light. When Mepacrine is given intramuscularly 
at the T6 stage, there is a delay of 2 to 4 hours 
before any of the morphological changes due to the drug 
are seen in the parasites. The first appearance is the 
collection together of the malarial pigment, but the 
parasite continues to develop without apparent arrest 
and there is little or no change in the parasite count 
for 5 to 8 hours. During this period the parasites 
have nearly all become young schizonts and at the same 
time many of them have begun to extrude the malarial 
pigment into the circulation. 
Up to this time, 5 to 8 hours, the patient usually 
feels comparatively well, but corresponding with the 
extrusion of the pigment by the parasite, (still a 
young schizont S1), the patient begins to feel the 
symptoms/ 
62. 
symptoms that are normally associated with a malarial 
paroxysm at sporulation time. These symptoms however, 
become gradually more severe with a rise of temperature 
and vomiting may follow. The latter may be such as to 
interfere with the subsequent administration of oral 
lepacrine. Many patients complain also of muscular 
pains and cramps. These clinical effects are of 
interest in that they constitute a malarial paroxysm 
due to the pigment being set free before the time of 
schizogony. The temperature chart shows a premature 
peak in what has hitherto been a regular tertian fever. 
The great fall in the parasite count occurs be- 
tween 4 and 12 hours after the injection. These are 
extremes of time and many cases have shown no change 
at 6 hours after the injection, yet have had no para- 
sites in films taken at 12 hours. The rapid clearance 
occurs at a time when the parasites have developed into 
middle and late schizonts (S2 and S3) and it appears 
that the young schizonts (S1) are only slightly 
affected. Cases with a heavy initial parasitaemia 
(6,000 - 14,000 per cubic mm) can be cleared in a 
matter of approximately 6 hours by this means. 
27 £resh and Relapse B.T. cases were injected at 
the T6 stage as described above. In the great majority 
of them, especially the Relapse cases, there occurred 
a rapid disappearance of asexual parasites with a 
premature/ 
.n.N .............. ....... p.... . . . 
Ì11C11Ci.99..M11119.9CCM9S1 .E1 .I ... . .. . . .. ...... .. IMMUNE 
BlerIEUTPTIMMINATIN 
III .. ..... ME. E ........ 




11 WI :.: .. .. . 
... :1SC1 ::.i 1 ilrt111111 .... 









I11II199UICI.:Ì mums. mum. .. .. 
Ìll 1111111111 IIIIIIIIPII 
iIii 1 
1111111 . 11111911 1 
U1999Ç9.°.9...i..°.Mm.CC.U :U: . .. ...  . , 
¡iiiiiiiii Ì10Ì1111Ì M. =MEMO ó_, T' . . A . . IN riÌS.1 ' _ . 
44 io 11 
rQ 
_ lÌ 1 
PEI 
::: 119 1M 
U. _ 
. ... p. ..... ME I .9Z ,:ïìr1i9 99 - iMM - M.MM .. .E.. E..  
' Ì1ÌÌ1::9I119 1........9C.. ..... ' =. II'II1 C1'I U": ..1EM..II9I. 1EI..ÌI.1 1 
1IIIIICIII1U1U1191Ì19CI111IUI9IUI191199 C: 
MEE ' . w . .
A 
TI2ioTdAi Td?io NO GUN* 
s.asvo zostoo = sxoozg-zo 
-SIJnI>zTi gol-:a 
4 iu 3--H 
. . S;rT;TSlé'd I1XHsX HoIHII L1II 
SLII23oVd .g Qsvs sasr-'L 
JO Ig g . _r. HoI3d 
I11 d 
_::::!r. ::: C:=1 . , ........ _. 
-, - íii9.:_. 
IIC..IIICU9SCI:G::. 
iiiiilC99Ci1.i1C11' 
Ciiiiii11ii9iiiiii ..9............ MEE.M.E. M  .. I: U: . \\M1 IM.. . n. nii I C...r.I,.99.....I. 3 
11riii%iiii111i EMME } 
41119111604 1i1;M .. 111.M .1: ' MM MINIM E. . 11 M.ME.'M... .M  .E M , : ; 
11°1111C111111111' ' m ' .f E .c -. t.
C11 111111C :1CI1C:'1S1=r C1' 
99. 
I1. IBM Ii IIUIIIU UCIIICIIIUIC.CU999I9 2 E\ E, .E . 
CC11111C1C11I111ICC111°.E 1C1111:11111C11111IICI: ..................... 
1CICIIC:I :: ICCI:CCC:C111sC9::1C1C1C1C1CCC: 
11111I111I11C11111C11C.E..: 1I1IC:7C1.I1I1111II' n ,a L 
...M19.99.9.11,..C.1II1 1. M. 
1CIIIII :I1 1.C:C111::: :=C=i1111MIME= 
11::1'úai'C '111.1,.111EEi :1:i 
U.U. , II :IUCII :9999 . :Ì' 
M .. 
° ' x E H MM.o .,. l O 
HN . oVd IVIi0 o QaSS 
sasTlo zoHoo _ H. r', . kt-, 
,.__ 
tt 77 -¡ . ..am.. s7.WISN{3i -91..M s ,o HDVss 91 s IV 11n.C'Ci 
iOZsOUi2 .g IlxoaaT u 0 MIME ii :;! 
- i11ID VI2i'd`zVrnt I g ,o sasro 19199M.- ..... . . . :
L2 NI vITAIaKSISa-nxasT .I111®i. 
JO +3oNiv o gal,. M.M .. b C M  . MEE Ml 
-,. mM 




(29 (3&ed)9Z`gZ mama 
63. 
premature clinical paroxysm. The results of the whole 
series are given in Figures 15 and 16 and in which the 
rapid rate of clearance can be compared with that 
obtained on the oral therapy courses. (Figs 1) 2) 8 
and 9). 
bone cases, however, showed a variation in the 
type of response both as regards clearance of parasites 
and clinical reaction. Thus a few experienced no 
clinical upset yet had a very rapid. parasite disappear- 
ance, while others suffered a severe reaction and after 
24 hours still showed scanty parasites. These observa- 
tions are difficult to explain but the following furthe 
experiments may throw some light on the problem. 
After injection of intramuscular Mepacrine had 
failed to cause the expected delay in the development 
of the dividing trophozoites, it was attempted to 
produce the hold -up by the administration of small 
oral doses of Mepacrine given before the parasites had 
reached the T6 stage. It was then thought that possibly 
too much Mepacrine destroyed the parasites, but the 
action of the drug and the delay before it takes effect 
were not fully realised., No hold -up effect was 
observed after these small oral doses and further ex- 
periments to produce this arrest were temporarily dis- 
continued. 
On the findings of the injection results, it was 
hoped that an even more rapid clearance of parasites 
could/ 
64. 
could be effected by diving heavy oral Mepacrine dosage 
in the first few hours following the intramuscular in- 
jection. The result of this attempt was again contrary 
to expectations as a true block of the parasites at 
the T6 stage was observed for the first time. This 
hold -up was produced in a number of cases but was found 
difficult to maintain for more than 24 hours as the 
frequent occurrence of severe clinical symptoms with 
vomiting usually prevented the maintenance of heavy 
oral dosage. It was also found that a single dose of 
0.8 gm. of Mepacrine given orally at the T4 stags of 
the parasite may likewise produce a temporary block at 




12 hrs. 24 hrs. 36 hrs. 48 hrs. 
9 ,000 4,000 50 Nil 
(T4) T5 (T6) Si S2 S3 M (T6) S1 
+ few T6 S1 + Scanty Ti + Scanty T1 T2 (T3) 
Scanty TC 
Predominant Stage is shown in brackets. 
Up to the present it has not been possible to in- 
vestigate as fully as desirable the plasma Mepacrine 
levels attained during the above injection and blocking 
experiments as such estimations could only be carried 
out from the end of March 1945 till the end of May 
1945. The results obtained to date in 8 injection 
cases are recorded in Section 8 of this report. 
A/ 
65. 
A further experiment was carried out to determine 
the oral dosage of Mepacrine required to produce the 
same rapid clearance effect on the asexual parasites 
as the injection described above. It was found that a 
dose of 0.2 gm. was insufficient but that a dose of 
0.8 gm. could effect the desired result. To allow for 
the delay in absorption, the oral dosage must be given 
about 5 hours earlier than the injection, thus corres- 
ponding to the T4 to T5 stage of the parasite. 
The effect of giving an intramuscular injection 
of 0.2 gm. of Mepacrine to a case with a tertian cycle 
of parasites at other stages of their development than 
T6 was also investigated. 5 suitable cases were in- 
jected when the parasites were either younger forms of 
trophozoites or schizonts and in none of these was 
there a rapid reduction in the parasite count nor did 
any premature clinical paroxysm follow the injection. 
From these 5 cases and from other observations, it was 
concluded that in order to produce the maximum rapid 
clearance of asexual parasites, it was necessary to 
inject the Mepacrine exactly at the T6 preschizont 
stage of the parasite cycle. 
An interesting experiment in connection with the 
above findings was to observe the effect of a Mepacrine 
injection in a case where two distinct B.T. asexual 
cycles were running concurrently (i.e. quotidian fever), 
giving/ 
66. 
giving the injection when only one of the cycles was at 
the T6 stage. It was found that in such cases, the 
cycle injected at the T6 stage could be eliminated 
within 24 hours, whereas the second cycle being at a 
different stage continued in its development until a 
day later when it also succumbed to the Mepacrine. 
Follow -up of cases given initial Mepacrine injections. 
A 6 month follow-up was obtained in 22 of the 
cases in which treatment was started by the above 
injection method. Of this number 12 suffered from a 
recurrence of malaria during this time, most of the 
relapses occurring within 2 months from the completion 
of treatment. Whereas this appears at first to be an 
unduly high relapse incidence, the figures are too 
small to draw definite conclusions, but would seem to 
indicate that further work along these lines might 
prove of interest. 
67. 
SECTION 5. 
PART B. OBSERVATIONS ON SOME FACTORS WHICH INFLUENCE 
THE RATE Ob CLEARANCE OF ASEXUAL PARASITES 
FROM THE PERIPHERAL BLOOD DURING THERAPY. 
The following observations are incidental to the 
main programme of work but are included in this report 
in the hope that they will be considered of sufficient 
interest and as they constitute a record of the re- 
sponse to therapy of the B.T. parasites encountered in 
the cases treated by this Team. 
1. An analysis of parasite counts in 189 Relapse 
cases treated on courses R1, (Mepacrine) and R2 + R3 
(Quinine plus Pamaquin), shows that a high initial 
count is reduced to nil almost as quickly as a low 
count by the same course of therapy. In order to 
illustrate this point, the cases have been classified 
into those with high, medium and low initial counts, 
and the average clearance rates for each of these 
groups on Courses R1 and R2 + R3, are shown in Figure 
17. It will be seen that after 48 hours of therapy, 
the average parasite counts of all groups fall within 
a close range of one another and all have disappeared 
at the end of 72 hours. 
This implies that in Relapse cases on treatment, 






FIGURE 17.(page 67). 
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irrespective of the degree of initial parasitaemia. 
2. Among military cases in B.N.A.F. and C.M.F. it was 
uncommon to find. B.T. cases with initial asexual para- 
site counts higher than 20,000 per cu mm. and such 
figures did not tend to increase even if no treatment 
was given. When it is considered that each B.T. 
merocyte usually gives rise to 16 merozoites (Italian 
strain), each of which is capable of starting a fresh 
generation in a red cell, it follows theoretically 
that the parasite count should multiply by 16 times 
each 48 hours. The fact that the count remains more 
or less constant, implies that the immunity mechanism 
of the host is able to cope with 15/16 of the parasites 
without the aid of drugs. In actual practice however, 
it is usual to find that there is a slight rise in the 
parasite count after sporulation, but this raised 
count falls rapidly for the first few hours and there- 
after decreases gradually as the parasites grow and 
become larger until the stage of schizogony is again 
reached. Figure 18 shows, in graphic form, an 
approximation to the general effects described above 
in an untreated case of B.T. Malaria. 
It would thus seem that the young trophozoite 
stage is a most critical period in the existence of 
the B.T. parasite. This may mean that the body defences 
are/ 
FIGURE 18.(page 68). 
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are best able to cope with the parasite at this stage. 
Another possibility is that the young trophozoites 
disappear from the peripheral circulation to continue 
their development elsewhere, but in B.T. Malaria there 
seems no reason to suppose that this occurs. 
Assuming that the young trophozoite is a most 
susceptible stage, it follows that any drug, which did 
nothing more than slow the parasite developmental cycle,, 
would result in a progressive diminution in the parasite 
count, since the parasite would not be able to make up 
its numbers within the 48 hour period in sufficient 
strength to replace those removed by the immunity 
mechanism. If the action of the drug were to take 
effect at the young trophozoite stage and so produce a 
retardation in growth, a much greater fall in the 
parasite count could be expected since the young 
parasite would be held in check at a time when it is 
most susceptible to phagocytosis. An example of this 
is seen in Case No.443 where an initial count of 
17,000 per cu mm. at stage Ti was reduced to nil 
within 24 hours by routine oral Quinine plus Pamaquin 
dosage. 
3. Although the young trophozoites (Tl) can be shown 
as above to be a comparatively susceptible stage of the 
parasite, the following observations tend to show that 
the slightly older trophozoites, T2, are relatively 
resistant/ 
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resistant to therapy. 
Quotidian fevers, having two separate cycles of 
approximately the same number of parasites in each 
cycle, are useful to show the effect of a given con- 
centration of a drug acting under the same conditions 
against two different stages of parasites. For example : - 
Case No. 310 Course Rl. 
Initial Day 1 Day 2 
Parasites /cu mm. 7,200 240 1 seen 
Stage T2 & T4 T3 T4 
Case No. 397 Course R1 
Parasites /cu mm. 5 1000 3000 Nil 
Stage T2 & T4 T3 
The counts given are those taken at the time that 
treatment was begun. When it is remembered that there 
is usually a delay before idiepacrine begins to take 
effect on the parasites, it will be seen that the 
parasites would have been slightly more advanced than 
the stages quoted before the drug acted. In the above 
two cases the late amoeboid trophozoites, present in 
the initial count, are presumed to have developed into 
schizonts which were subsequently destroyed, while the 
more firmly established young trophozoites though some- 
what retarded, developed into young amoeboid forms 
which were found 24 hours later. In Case :310, one 
trophozoite, still in the amoeboid stage, was found 
after 48 hours. 
Other/ 
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Other examples are 2 cases with semi- continuous 
fever showing a wide variety of parasites in different 
stages of development when treatment was started. 
Case No. 309 Course Rl 
Parasites/cu mm. 
Stage 
Initiai Dayl Day 2 
8,900 240 Nil 
Ti T2 T3 T4 S3 T3 
Although 5 different stages were present in the 
initial count, only young amoeboid trophozoites (T3) 
were found after 24 hours. This shows the comparative 
resistance of the growing young trophozoite. 
Case No. 240 Course R1 
Initial Day 1 Day 2 Day 3 Day 4 
Parasites /cu mm. 10,500 4,800 500 30 Nil 
Stage T1 T2 T3 T4 T5 T3 T4 T6 
This case shows not only the resistance of the 
growing trophozoite compared with the other forms, but 
also the inhibition of development due to Mepacrine. 
The above observations help to explain why treat- 
ment commenced either at the stages of very young or 
very late trophozoites, often brings about a rapid 
clearance of parasitaemia, whereas such rapid dis- 
appearances are seldom seen when treatment is started 
at the stage of growing trophozoites. 
4./ 
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8 cases show young 
trophozoites on Day 1. 
1 case only shows young 
trophozoites on Da' 1. 
Only very small delay in 
the division and young 
schizont stage 
Many parasites delayed at 
the division and young 
schizont stage. 
Great general fall -off 
on Day 1. 
Small general fall -off 
on Day 1. 
TABLE 8. A comparison between the effects of Mepacrine 
and Quinine plus Pamaquin when treatment is 
started at the T4 stage of the asexual 
parasite cycle. (20 cases of B.T. Relapse 
Malaria.) 
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4. A comparison of the effects of Mepacrine alone and 
Quinine plus Pamaquin when given to a group of cases 
in which the stage of parasite at the start of treatment 
was the same, is recorded in Table 8. The principle 
differences observed after 24 hours are noted at the 
foot of the Table. This shows that in the 10 cases 
treated on Mepacrine, schizogony was not prevented so 
that young trophozoites were found 24 hours later, 
whereas in the 10 cases treated on Quinine plus Pamaquin, 
parasite development was inhibited before schizogony 
in all but one case. 
It would seem from the above comparison that the 
differences noted are not so much related to a variance 
between the mode of action of Mepacrine and Quinine 
plus Pamaquin, but rather that the latter therapy course 
is more rapid in its initial action on the parasite. 
It is necessary to administer Mepacrine at an earlier 
stage of the parasite development to produce a similar 




THE "RELAPSE FACTOR" IN BENIGN TERTIAN MALARIA. 
It has been consistently observed that in B.T. 
Relapse infections a comparatively high initial asexual 
parasite count following a short period of premonitory 
symptoms, is a characteristic finding. In contrast with 
this, B.T. Fresh infections have been noted to have a 
low initial asexual parasitaemia with a much longer 
period of antecedent clinical manifestations. 
In this respect it was considered interesting to 
correlate the initial parasite count with the days of 
symptoms in the form of a simple mathematical expression. 
This was termed the "Relapse Factor", "R", and is 
obtained as follows: - 
R = Initial asexual parasite count er cu.mm. 
Days of symptoms x 100 
Examples. 
Fresh Case. Initial count = 800 per cu.mm. 
Days of symptoms = 4. 
R = 800 
4 x 100 
- 2.0 
Relapse Case. Initial count = 7,000 per cu.mm. 
Days of symptoms = 2. 
R 
= 000 - 35.0 2 x 100 
In effect the Relapse Factor is a measure of the 
degree of peripheral asexual parasitaemia that the 
individual/ 
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individual is able to withstand before feeling acutely 
ill, and thus possibly represents the tolerance to the 
malarial toxin. 
It was hoped that a correlation would he found 
between this factor and some other feature of the dis- 
ease and that the factor would also provide additional 
information in cases where there was doubt as to 
whether the infection was Fresh or Relapse. On taking 
the Relapse Factors in 156 Fresh cases and in 254 
Relapse cases of B.T. Malaria, it is seen that cases 
having a Factor of less than 15 are mostly Fresh in- 
fections, while nearly all the Relapse infections have 
a Factor higher than 25. Apart from this observation, 
no other application has so far been found between the 
Relapse Factor and other characters of Malaria in- 
fections. 
The Relapse Factor is not uniformly high in all 
Relapse cases, or invariably low in Fresh infections, 
and while the average figures are consistent, some 
inexplicable deviations from the general rules are 
found. It should be noted however that the criterion of 
Nresh or Relapse is based upon a clinical history and 
hence no absolute certainty is possible under these 
circumstances. 
Figure 19 shows graphs of the average Relapse 
Factor of all Fresh and Relapse cases for each month 
from/ 
FIGURE 19.(page 74). 
FIGURE 19. MONTHLY RELAPSE FACTORS 
JULY 1944 - MAY 1945. 
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from July 1944 to May 1945. (The figure for September, 
1944, was not obtained as the Research Team was moving 
from North Africa to Italy during that month). It will 
be seen that the very high Factors in the Relapse 
cases from August to November, fell gradually through- 
out the Winter and Spring until Apri]. when they were 
but little higher than the Factors for the cases who 
gave no previous history of Malaria. The Factors for 
the latter cases had in contrast tended to increase 
gradually over the same period. It would have been 
interesting to see whether the two groups would have 
again diverged during the Summer months. 
Until 15th November, 1944, the troops in. the areas 
in which this work was carried out were issued with 
0.1 gm. suppressive Mepacrine daily. The highest 
bactors in the Relapse cases thus corresponded not 
only with the height of the Malaria season and hot 
weather but also with the suppressive Mepacrine. If 
the high ractors do bear any relationship to the latter, 
then this would imply that relapses occurring while 
under the influence of suppressive Mepacrine manifest 
themselves with great suddenness and with a heavy 
parasitaemic infection. So few patients openly admit 
that they have not taken any suppressive Mepacrine, 
that an insufficient number of such cases are available 
for comparison with the above. It can be stated, how- 
ever/ 
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however, that most of the cases with very heavy B.T. 
infections that have been studied by this Team, have 
had some suppressive iïlepacrine , and that few heavy 
parasitaemias have been encountered amongst those who 
have had little or no suppressive Mepacrine. 
77. 
SECTION 7. 
CHRONIC RELAPSING CASES. 
Cases of Malaria with multiple recurrences occur- 
ring in C.M.F. were sent to one of two centres for 
investigation and treatment. Cases from Sicily and 
Southern Italy went to No. 92 (Br) General Hospital 
in Naples and cases from Central and Northern Italy 
were directed to No.2 Malaria Research Team in Rome. 
A total of 116 cases (comprising 112 B.T. infections 
and 4 M.T. infections) of this category were dealt 
with by this Team between October, 1944, and May, 1945. 
It is felt that the observations and results in the 
group of B.T. cases are worth recording briefly under 
the headings below. 
1. Number and frequency of attacks. 
Of the 112 recurrent B.T. cases, 105 had had 5 
or more attacks, 14 had had 10 or more attacks and 4 
had had 14 or more attacks. The average number of 
attacks for all cases was 7. 
In the majority of the cases the primary attack 
and the recurrences had occurred over a period of 
12 - 15 months, and many patients had contracted their 
first infection during the Summer campaigns of 1943 
in Sicily and Southern Italy. 
It was interesting to note how infections con - 
tracted/ 
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contracted in certain areas about the same time had a 
particular tendency to repeated relapses and this may 
probably be explained as being a characteristic of the 
strain of the local infecting parasite. One Company of 
specialised troops, who for operational reasons spent 
two nights near a river in the Barletta area. in Sept- 
ember, 1943, had an especially high incidence of cases 
with multiple recurrences, and several of their men 
are included in the group reported here as having had 
more than 10 attacks. Another strain of parasite with 
a tendency to several relapses was encountered in cased 
who contracted their primary infection in the Anzio area 
during August and September of 1944. 
2. Clinical Notes. 
Nearly all the cases of this series were referred 
for investigation by other medical units who had given 
them the standard C.M.F. Malaria treatment (same as 
Course 5). They thus arrived in a quiescent phase of 
their infection and had usually already been 7 to 10 
days in hospital. 
The clinical findings in these cases show that in 
general the recurrent B.T. infection was much more of 
a "nuisance disease" than a cause of chronic ill -healt 
or cachexia. Many of the cases were sent to the 
Research Team for special treatment on account of 
their repeated travels in and out of hospitals which 
rendered/ 
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rendered them unsuitable to be counted against the 
effective strength of their units. Cases of this 
nature had few symptoms between attacks and their 
general health appeared to have suffered little. Other 
cases complained of gradual loss of weight, easy 
fatigue, headache, and inability to stand cold. A mild 
degree of hypochromic anaemia was present in many such 
cases and responded slowly to iron therapy. 
Splenic enlargement could be detected on physical 
examination in about 50% of all these cases, but the 
finding of a really large and hardened spleen was 
present in only 3 or 4 cases of the whole group. 
In some cases with large spleens, radiographs taken 
before, and at intervals after the subcutaneous in- 
jection of 0.5 cc Adrenalin showed that the spleens 
were capable of contracting down to about one third 
of their size within 10 minutes of the injection. 
3. Treatment. 
It was decided to use these cases for a trial of 
Mepacrine versus Quinine plus Pamaquin in the treatment 
of chronic B.T. Malaria. Two lines of therapy were 
therefore adopted and patients were treated on these 
in rotation. 
The 55 cases treated on Mepacrine were first 
given a repeat of the Mepacrine dosage of the standard 
80 . 
O.M.F. course and the plasma levels attained during 
this were estimated. Cases in whom these levels reached 
a satisfactory value, were given no further Mepacrine 
for 7 days and were sent to a Convalescent Depot nearby. 
While there, they were given two further courses of 
oral Mepacrine comprising 0.2 gm T.I.D. for 5 days with 
an interval of 7 days between these courses. They 
thus received a total of 8.5 gm of oral Mepacrine over 
a period of 29 days. Cases who failed to show satis- 
factory plasma Mepacrine levels, were given intra- 
muscular injections of Mepacrine and further levels 
estimated as described in Section 8 of this report. 
These cases were also sent to the Convalescent Depot 
for the same oral dosage as given to the previous 
group and thus all of them received a minimum of 8.9 
gm. of Mepacrine of which at least 0.4 gm. had been 
given intramuscularly. 
The other group of 50 cases were given an initial 
course of Quinine 1.0 grains plus Pamaquin 0.01 gm T.I. 
for 7 days. They then received no treatment for 7 day 
and were sent to the Convalescent Depot. There they 
were given two further courses of Quinine 10 grains 
plus Pamaquin 0.01 gm T.I.D. for 5 days with an interval 
of 7 days between these courses. They thus received 
a total dosage of Quinine 510 grains and Pamaquin 
0.51 gm given over a period of 31 days. None of these 
cases was given any additional treatment. 
It/ 
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It will be noticed that an intermittent dosage 
regime was adopted in these chronic cases. This method 
was chosen for three main reasons. First, it was felt 
that a trial should be made of the value of intermittent 
iñepacrine as against intermittent Quinine plus Pamaquin 
in contrast to prolonged continuous courses with these 
drugs. Secondly, any undesirable effects likely to be 
produced by prolonged administration would be minimised 
by this method. Thirdly, it was considered that all 
these patients would benefit greatly from a period. of 
3 to 4 weeks supervised convalescence, and method of 
dosage allowed treatment to be spread over this time. 
No toxic manifestations were encountered in any 
of the cases during treatment with Mepacrine or Quinine 
and Pamaquin and the patients were allowed to remain 
ambulant throughout the courses. It can be recorded 
here that many patients receiving the Quinine plus 
Pamaquin therapy stated, after about 10 days treatment, 
that they had not felt so well for a long time. 
4. Follow -up of Chronic Cases. 
The same follow -up system was adopted for these 
recurrent cases as was used for the active infections 
treated on the routine therapy courses. The follow -up 
took place mainly during the Winter and Spring months 
when the chances of re- infection were minimal. 
It/ 
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It was possible to obtain 6 -month follow-up 
particulars from 72 of the 105 patients who were 
treated on the intermittent therapy courses of Mepa- 
crine or Quinine plus Pamaquin. The results are shown 







Quinine - Pamaquin. 
Number treated 55 50 
No. followed 
for 6 months. 
38 34 
* 
RELAPSE. 17 NIL. 
NO RELAPSE. 21 34 
* One man wrote that he had felt shivering and had 
treated himself with a few doses of an Italian 
patent medicine. Another patient was subsequently 
admitted to hospital as a suspected case of 
malaria but no parasites were found on blood 
examination. 
In the 17 patients who relapsed after the 
Mepacrine course, the recurrence took place after an 
average period of 7.5 weeks following the completion 
of treatment. 
The above figures are strikingly in favour of a 
30 day course of intermittent Quinine plus Pamaquin 
therapy as being a remarkably effective treatment for 
recurrent B.T. Malaria. Further reference to the 
success,/ 
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success of this course will be made in PART FOUR of 
this thesis, when discussing the general conclusions 





ESTIMATIONS OF PLASMA MEPACRINE LEVELS. 
From October, 1944, until January, 1945, the 
malaria Research Team was co- operating with No.1 Field 
Section of the Malaria Research Unit who went to 
Italy from Oxford to study plasma Mepacrine levels in 
cases of Malaria and particularly in those cases where 
the infection had appeared during the taking of sup- 
pressive Mepacrine. It was arranged that the Field 
Section should also carry out plasma Mepacrine estima- 
tions on the cases being treated by the Research Team 
in their therapeutic trial and that patients being 
treated on account of multiple recurrences of Malaria 
should have their Mepacrine absorption investigated. 
When No.1 bield Section returned to U.K. in January, 
1945, the special equipment required for Mepacrine 
estimations was taken over by the Research Team, but 
as it was necessary to wait for a new Ultra- violet lamp 
for the Hilger fluorimeter to be sent from U.K., it 
was not possible to begin Mepacrine estimations until 
22nd March, 1945. These were done from 22nd March 
until 23rd May when the Team ceased work in Italy. 
The small total number of 330 estimations done during 
this period was determined by the fact that no further 
personnel were available for the extra laboratory work 
involved/ 
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involved. The results obtained in this somewhat limited 
study may be briefly discussed under 3 headings. The 
plasma Mepacrine levels were estimated by a modification 
of Masen's method (J. Biol. Chem. 148. 1943) and a 
tiilger Spekker photo -electric fluorimeter was used. 
1. Plasma levels during therapy courses. 
Estimations were made of the plasma Mepacrine 
levels attained at intervals throughout the therapy 
courses Nos. 1, 2, 3, 4, 5 and R.1. The results were 
similar to those obtained earlier by the Field Section 
and showed that an average plasma Mepacrine level of 
40 to 45 micrograms per litre was reached after 48 
hours administration of Mepacrine in all the treatment 
courses, and that such a level was maintained fairly 
steadily thereafter. Differences in initial dosage, 
high or low, affected the rate at which the steady 
plasma level was attained, but did not materially alter 
the equilibrium figure ultimately established. Con- 
siderable individual variations occurred from the 
average levels quoted but in general it was not found 
possible to detect any obvious correlation between 
this evidence of Mepacrine absorption and other findings 
such as the rate of clearance of asexual parasitaemia 
or subsequent tendency to relapse. It is of interest 
to record in passing that a plasma Mepacrine level of 
25 to 30 micrograms per litre was found by the Field 
Section/ 
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Section and other workers to be the average level 
achieved on a routine daily suppressive dosage of 0.1 
gm. Mepacrine. Here again, however, there is apt to be 
a wide margin of individual variation, which may be an 
important factor in those cases who develop an acute 
attack of B.T. malaria while adhering strictly to the 
regular suppressive dosage. 
2. Plasma levels in cases in acted with Mepacrine at 
the T6 stage of the parasite. 
A preliminary investigation was made of the plasma 
levels attained in 8 cases who received 0.2 gm. Mepacrine 
by intramuscular injection at the T6 stage of the B.T. 
parasites and who were given no oral Mepacrine during 
the subsequent 16 hours. Levels were taken at 3? hours 
and 16 hours after the injection but in the 1 case 
done by the Field Section, levels were obtained at 
2, 1) 2, 4, 8 and 12 hours after injection. 
These results, though few in number, are interest- 
ing because they can be compared with the fall -off in 
asexual parasite count which occurs so rapidly when 
Mepacrine is injected at the T6 stage. Figure 20 shows 
graphs of the plasma levels attained and rate of clear- 
ance of asexual parasites that occurred in these 8 cases. 
¡These findings suggest that a high concentration of 
Mepacrine in the plasma is reached half an hour after 
injection but falls within 32- hours and continues to 
fall/ 
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fall until 16 hours which is the last recorded level. 
The maximal parasite clearance effect occurs during 
the period from 5 to 12 hours after the injection. The 
patients studied remained afebrile during this time. 
Studies by Shannon and other workers on the dis- 
tribution of Mepacrine in the blood, show that the fall 
in the initially high plasma level is brought about by 
the transference of the drug to the circulating red 
and white blood corpuscles and also to the tissues. 
Whereas insufficient cases have been studied by the 
Research Team to draw any definite conclusions, it 
would appear likely that the time of parasite clearance 
observed, corresponds with this transfer of the drug 
from the plasma to the parasitised red cells. Further 
work along this line might prove of interest in the 
study of the action of Mepacrine or other anti - malarial 
compounds. 
3. Plasma Mepacrine levels in cases with multi le 
recurrences of B.T. Malaria. 
Plasma Mepacrine levels were estimated in a group 
of patients who had suffered from multiple recurrences 
of B.T. malaria and who were treated with further 
Mepacrine courses to investigate whether failure of 
absorption of the drug might be a factor in allowing 
their infection to relapse so frequently. A number of 
such cases was studied by the Field Section who found 
that these patients did in fact attain plasma levels 
which/ 
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which were lower than average while being treated with 
the standard therapy dosage. Similar results were 
obtained in a smaller group of cases investigated by 
the Research Team and the following example is worthy 
of special comment. 
Case No. 116.C. B.T. Malaria 14 attacks between 
September 1943 and March 1945. He was given oral 
Mepacrine 0.2 gm Q.I.D. for 2 days at the end of which 
This plasma Mepacrine level was found to be nil. The 
fact that he took the tablets was established. After 
3 further days on oral Mepacrine 0.1 gm T.I.D. the plasma 
level was 4 micrograms per litre. In each of the 2 
following days he was given an intramuscular injection 
of 0.2 gm Mepacrine and the levels taken 18 hours after 
each injection were 5 and 18 micrograms per litre 
respectively. This case is quoted as an example of 
how Mepacrine given in the usual therapeutic dosage 
may be present in the plasma in very low concentration 
in cases of recurrent Malaria. 
8 of the cases of recurrent B.T. Malaria in whom 
the plasma Mepacrine levels were estimated by No.1 
Field Section during therapy are known to have relapsed 
subsequently. The average plasma levels attained by 
this group while on the standard course of oral 
Mepacrine were 36.0 and 36.5 micrograms per litre as 
compared with levels of 44.8 and 40.2 micrograms per 
litre/ 
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litre which were attained after the same dosage of a 
similar course by a group of cases undergoing routine 
treatment. Of these 8 cases, 6 had received two intra- 
muscular injections of 0.2 gm Mepacrine at the end of 
the 5 days oral course and the average plasma levels 
on the days following these injections had been 41.0 
and 46.0 micrograms per litre respectively. In this 
small group who relapsed, the additional raising of 
the plasma Mepacrine level by injection did not appear 
to have been efficacious in preventing a recurrence. 
PART TWO. 
AN INVESTIGATION OF TAIE ACTION OF 
PAMAQUIN AND PALUDRI3E (M. 4888) IN THE 
THERAPY OF BENIGN TERTIAN MALARIA. 
9G. 
-SECTION 1. Introduction. 
In the Summer of 1945 the Malaria Research Team 
returned to Britain from Italy and was re- equipped to 
proceed to India for the study of problems of interest 
in malaria therapy in the Far East. The sudden end of 
hostilities against Japan altered this programme as it 
became apparent that with the cessation of active 
military operations in the East, the local problems of 
malaria would become little more than those of string- 
ent mosquito control and personal protection amongst 
relatively static troops in selected locations. 
Following the institution of rigid Mepacrine discip- 
line among such troops, the incidence of malaria, 
especially M.T. infections, had declined to a minimal 
level. It was felt therefore that little was to be 
gained by sending a Research Team to work on the 
prevention and treatment of fresh infections, particul- 
arly when the more acute operational demands for 
conserving manpower no longer existed. On the 
other hand, the Services would at once begin to return 
to Britain in their thousands, troops who had lived in 
malaria- ridden lands and who would be returning home as'' 
reservoirs/ 
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- reservoirs of Mepacrine- suppressed Plasmodia from which 
much recurrent sickness could be expected to arise. 
There were also large numbers of those liberated from 
Japanese prison camps to be cared for, who had received 
little or no treatment for malaria during over three 
years of imprisonment in hyper - endemic areas of infect- 
ion. It was therefore decided by the War Office, in 
consultation with the Medical Research Council, that 
the Research Team could be most usefully employed in 
the treatment of cases of malaria amongst personnel 
returned from overseas and that such work would provide 
an opportunity for the further study of anti- malarial 
compounds v ith .particular reference to their effect in 
producing a radical cure of the infection. 
In September 1945 the Team was accordingly attach- 
ed to the Royal Herbert Military Hospital at Woolwich 
where excellent clinical and laboratory facilities were 
available and which served a Garrison area in which 
large numbers of troops were stationed on their return 
from service abroad. It was decided to work only on 
cases of Benign Tertian malaria as this type was the 
one most likely to prove a recurrent "nuisances disease 
and trie chances of continued activity of Malignant 
Tertian infections were remote after prolonged suppress - 
ve Mepa.crine dosage, which had been continued during - 
the voyage home and for four weeks after disembarkation 
ior'all personnel. The Team started work at Woolwich 
early/ 
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.early in October 1945 and it was.found that the number 
of cases admitted and. suitable for therapeutic research{ 
was actually greater than the number available for 
investigation in Rome during the corresponding months 
of 1944. 
The programme of work was devoted - mainly to the 
study of the action of two drugs, Pamaquin and the new 
synthetic compound Paludrine (M.4888). Pamaquin was 
selected for special attention as of all the many anti - 
malarials tried out in various parts of the World, it 
alone had been found to lower consistently the relapse 
rate in Benign Tertian malaria. Much work also had 
been started in America on the pharmacology of Pamaquin, 
and preliminary reports showed that a great deal of 
promising information was likely to be learned from a 
study of the blood concentration and urinary break -down) 
products of this drug. Finally it was desired to con- 
tinue and confirm the observations made by the Team in 
Italy on the action of Pamaquin on asexual B.T. para- 
sites during an active infection. 
It is possible to report in this thesis the 
results of the therapeutic trial of Pamaquin when used 
as the only anti- malarial drug in the treatment of a 
.series of cases of B.T. malaria. As this work was 
only started in the Autumn of 1945, follow -up figures 
over a period of six months are not available and up 
o the time in January 1946 when the author left the 
eam/ 
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Team on being released from the Army, only the initial 
stages of the biochemical investigation of Pamaquin 
had been planned and started. A brief mention of the 
latter work will be given however, as it will indicate 
the present trend of thought in regard to Pamaquin and 
show how this previously much -maligned drug is at last 
taking a place in the limelight of malaria therapeutic 
research. 
The other drug with which the Team was working at 
'Woolwich, was the compound M.4888, later designated 
"Paludrinett,which had been produced in 1945 by Imperial 
Chemical Industries (Pharmaceuticals) Ltd. at their 
research department in Manchester. This drug, one of 
a very large series of compounds tested for anti-malar- 
ial activity, was synthesised by Rose & Curd and was 
tried out in the treatment of chicken malaria by Davey, 
rorking in the sanie laboratories. It was found to be 
outstanding from other drugs in being able, in 
mall non -toxic doses, to arrest not only the blood 
orms of the parasites, but also the extra- erythrocytic 
issue phases of the infection that are the usual cause 
f death in chicken malaria. Although the latter forms 
e- appeared when dosage with M.4888 was discontinued 
rid proved fatal through blockage of cerebral capill- 
aries, the mere fact that the drug was capable of actin 
on the tissue forms when given in therapeutic doses,at 
once attracted attention and suggested that it might 
cr ove/ 
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-prove worthy of trial in human infections. While the 
existence of extra- erythrocytic parasites in human 
malaria has never been demonstrated,there are strong 
reasons for, believing that they must be present, on 
the grounds of analogy with avian malaria, on the fact 
that there is still a missing link between the mosquito 
injected Sporozoite stage and the young Trophozoites 
in the blood, and as the resistant forms responsible 
f ur relapses long after all traces of parasitaemia 
have been cleared by treatment. Any drug therefore 
which might act on these hypothetical tissue parasites 
in addition to killing the asexual stages in the blood, 
would therefore be of great interest and possible value 
in the treatment of human malaria, and especially the 
types of infection most prone to relapse. 
M. 4888 was first tried on cases of human malaria 
at the Liverpool School of Tropical Medicine and was 
found to be very successful in the treatment of the 
clinical attack in both B.T. and M.T. infections. The 
drug, administered orally in the form of tasteless, 
white tablets was effective in clearing parasitaemia in 
dosage as low as 10 Mgm. given twice daily. It pro- 
duced no toxic manifestations, other than occasional 
nausea and epigastric discomfort within a few minutes 
of swallowing, in doses as high as 500 -700 Mgm. twice 
daily and so appeared to be a drug with a very con- 
siderable margin of safety between the effective 
therapeutic/ 
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._therapeutic dose and the toxic dose. rn the control 
of malaria fever and termination of the clinical attack, 
Paludrine was at least equal to Quinine and Mepacrine 
and with the additional advantage of low toxicity, 
promised to be a real advance on other anti- malarials. 
In one respect only, were the early hopes of it not 
fulfilled, for B.T. cases treated with full courses of 
the new drug continued to show a relapse rate at 
least as high as with Quinine or Mep:acri _le . 
Following the initial trial at Liverpool, 
supplies'of Paludrine were made available for more 
extensive investigation by Army Research Teams. One 
series of cases was treated at Colchester where the 
relapse incidence in B.T. infections was shown to com- 
pare unfavourably with a control series treated on 
Quinine plus Pamaquin, although the drug worked well 
in the control of the active malaria attack. Another 
batch of the compound was sent to Brigadier Hamilton 
Fairley working in Australia and was used in experiments 
to evaluate zts action as a prophylactic against 
mosquito -borne malaria infections. Fairley's work 
showed that Paludrine, in doses as low as 25 Mgm. a 
day, was a true causal prophylactic against Malignant 
Tertian malaria, acting apparently on the primary 
tissue stages of the parasite so that blood stream 
infection did. not develop. That in itself was a 
tremendous advance over other drugs and ensured for 
Paludrine/ 
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- Paludrine a lasting place of the greatest value in 
the prevention of malaria. It meant, in short, that 
by taking one tablet daily (Fairley's recommended 
dose = 100 Mgm.) , immunity from M.T. malaria was 
ensured. It is doubtful whether the implications 
of these facts have yet been widely realised, as the 
results are still unpublished and the supplies of the 
drug still limited to experimental use; but it is 
indeed trie dawn of a new era in tropical medicine 
when what is perhaps the most widespread fatal infect- 
ion of ali, can be prevented by a single daily tablet. 
In B.T. infections, Fairley found that Paludrine 
was not a complete causal prophylactic, in that it 
did not prevent mosquito -borne Sporozoites from estab- 
lishing asexual parasites in the blood -stream, althoug 
the latter were suppressed for as long as the drug 
was administered, in the same manner of suppression as 
with Mepacrine. His results in the therapy of both 
M.T. and B.T. acute cases with M. 4888, were in agree- 
ment with the Liverpool work and he observed that in 
both infections the drug exerted its action by being 
a powerful schizontiôide. The above findings by 
Fairleyts Team were recorded in a Progress Report of 
that unit in February 1946 and work with Paludrine 
is being continued. 
The third therapeutic trial with Paludrine was 
allocated to the Malaria Research Team at Woolwich 
and/ 
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and it was decided to adopt two lines of work. The 
first of these was to study on a relatively small 
series of cases, the precise mode of action of the 
drug on the parasites of active B.T. infections, using 
methods of parasite counting and observation as had 
been employed in Italy to study the effects of Mepacrine. 
The results of this investigation, the first of its 
kind, were reported to the Medical Research Council 
in December 1945, and will be recorded in this thesis. 
The second line of work was to examine the possibility 
of combined therapy with Paludrine and Pamaquin and 
to see whether the two drugs might have an additive 
effect in reducing the relapse rate in B.T. malaria 
cases. The early stages of this work are also 
mentioned in this thesis. 
It was realised that since most of the cases 
seen at Woolwich had contracted malaria in India or 
Burma, it might not be possible to draw conclusions 
as to the comparative efficacy of drugs on the basis 
of previous studies made in dealing with Italian and 
North African strains of parasite. A short pre- 
liminary study was therefore made to determine the 
essential features of the parasites encountered in 
the cases at Woolwich and the effects of Mepacrine 
therapy in producing microscopic changes and clearance 
of/ 
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-. -of parasitaemia, were noted in a short series of cases 
Thereafter the ten -day Quinine -Pamaquin course (R2) 
was adopted as a control treatment for the subsequent 
work. 
Another point to which attention was paid in 
the investigation at Woolwich, was to select for the 
purposes of trial therapy, only those cases in which 
the degree of parasitaemiá and other features indicat- 
ed that spontaneous recovery was unlikely to result 
within a few days in the absence of specific treat- 
ment. This was important as many of the patients 
had acquired a considerable immunity from previous 
attacks and those who were having their first 
Mepacrine- delayed attacks, might still have retained. 
sufficient of the drug to modify the clinical course 
of the acute phase. Evidence of a mounting or 
sustained asexual parasitaemia over a period of 48 
hours, was therefore adopted as themaIiIcriterion for 
the acceptance of a case as being suitable for study. 
SECTION 2. 
99. 
The Action of Pamaquin in 
the treatment of B.T. Malaria. 
28 cases of active Benign Tertian malaria were 
studied during treatment with Pamaquin, given in a 
dosage of 0.01 gramme .three times daily for 10 days. 
No other anti- malarial drug was given to these patients. 
The response to therapy was noted clinically and by 
observations on thick blood films examined at 24 hour 
intervals, recording the changes in the parasites as 
well as the asexual and sexual parasite count per 
cubic millimetre. The results obtained may be con- 
sidered conveniently under the following headings. 
1. Clinical Response. 
The drug was well tolerated during the acute, 
febrile stages and caused no vomiting or other 
disturbances. The average duration of pyrexia after 
the start of treatment with Pamaquin was 3.0 days, as 
compared with 2.0 days in the control cases treated 
with Quinine plus Pamaquin. The patients were allow- 
ed up after the temperature had remained normal for 
48 hours and in no case did the drug need to be stopp- 
ed on account of toxic manifestations. In 2 cases 
there was slight cyanosis evident during the last 3 
days of the 10 -day course, and 3 patients complained 
of mild abdominal discomfort which appeared to be 
associated with fairly marked splenic enlargement. 
Leucocyte counts, done repeatedly during treatment in 
connection/ 
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connection with the parasite counts and Haemoglobin 
estimations at the start and end of therapy, showed 
no evidence of toxic suppression of haemopoietic activ 
ity and no sign of increased blood destruction. 
There were no abnormal urinary findings. 
The general clinical impression formed was that 
Pamaquin alone was quite capable of controlling the 
malaria fever, although it was slower in producing 
this effect than Quinine, Mepacrine, or Quinine and 
Pamaquin given together. 
2. Clearance of Asexual Parasitaemia. 
The average duration of treatment required to 
clear asexual parasites from the peripheral blood 
was 3.1 days, as compared with 1.5 days for the con- 
trol Quinine- Pamaquin cases. 
Figure 21 shows the rate of disappearance of 
asexual parasites on Pamaquin therapy by plotting the 
average of parasite counts done at 24 hour intervals 
from the start of treatment. A logarithmic scale 
has been used in this graph. 
Figure 22 indicates the percentage number of 
cases in which asexual parasites were present on each 
day of treatment and shows that, in the majority of 
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FIGURES 21,22.(page 100). 
FIGURE 21. CTEARANCE RATE OF ASEXUAL 
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FIGììRE 23. CLEARANCE RATE OF GÁITTOCiTE3 
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101. 
3. Clearance of Gametocytes. 
Figure 23 shows in graphic form (logarthmic 
scale), the average daily gametocyte counts from the 
start of therapy, and Figure 24 records the percentage 
number of cases in which sexual parasites were present 
initially and on each of the first 6 days of the 
course. 
The average duration of Pamaquin treatment re- 
quired to clear the peripheral blood of gametocytes 
was 2.5 days.. Whereas this time compares unfavour- 
ably with the gametocyte clearance time of Quinine 
alone (2.02 days in 46 B.T. Fresh infections in C..,.F.) 
or Quinine plus Pamaquin, (1.5 days average in 130 
cases in C.1.F. a.úd at Woolwich), it will be noted 
tnat Pamaquin by itself is able to clear tie blood 
of gametocytes in a time as short, or less, than it 
requires to get rid of the asexual parasites.'  . ' This 
is in direct contrast -to the findings in therapy 
with Mepacrine alone, which, in both high and low 
initial dosage, produced clearance of the asexual 
forms in less time than disappearance of gametocytes. 
4. Effects on the development of the 
B.T. asexual cycle. 
As might be expected from the time taken by 
Pamaquin to check both the clinical fever and asexual 
parasitaemia in active B.T. infections, there is a 
considerable delay before its action on the asexual 
developmental/ 
102. 
- developmental cycle becomes evident on microscopical 
study. Compared with Quinine and Mepacrine, Ahich 
produce demonstrable retardation of parasite develop- 
ment within 12 to 18 hours, this effect usually occurs 
much later, - after 24 hours -, with Pamaquin, a fact 
which has no doubt contributed previously to the view 
that this drug has little direct action on asexual 
parasites. 
When the Pamaquin- effect does begin, however, 
there is a marked sloing in the maturation of the 
growing trophozoites as occurs with Quinine and 
Mepacrine, though it differs from the latter drugs 
in causing very little tendency to an arrest of 
parasite development at the pre -schizont stage (T6 in 
the parasite notation scheme described in Part One). 
The trophozoites therefore are subjected to a general 
inhibition in their growth, but appear to undergo 
nuclear segmentation relatively unimpeded and reach 
the later stages of schizonts before they are destroy- 
ed. The maximum destructive effect of Pamaquin would 
seem to be exerted on late schizonts and merocytes 
(S 2, S 3 & M), and those parasites that survive this 
phase and escape from the bursting merocyte to become 
young trophozoites again, may struggle on until the 




5. Morphological effects on the 
asexual parasites. 
Collapse of the amoeboid forms of trophozoite 
occurs with Pamaquin action,though the change is later 
than with Mepacrine therapy and not so intense. 
Conglomeration of malarial pigment in late 
amoeboid trophozoites is often seen with Pamaquin, 
as with Mepacrine, and the bunched up pigment may be 
extruded from the parasite cell. If this liberation 
of pigment should occur nen massen from large numbers 
of late trophozoites, at approximately the same time, 
it may result in a typical attack of rigor and malaria 
fever. Such a clinical paroxysm may be caused in 
this manner at a time when the asexual parasites are 
only at the stage of young de- pigmented schizonts, 
so that the fever occurs prematurely according to the 
usual timing of the parasite cycle. A good example 
of this effect, produced by oral Pamaquin therapy, 
is depicted in Figure 25 (Case No. 452) which shows 
the occurrence of a peak of temperature coinciding 
with the extrusion of pigrnent from late amoeboid 
trophozoites. This case shows also the slowing effect 
11- 
of the drug on the maturation of the late tróphozo.ites 
and it will be noted that the maximum fall in the 
asexual parasite count occurred within 6 hours during 
hich the developing schizonts were destroyed. 
FIGURE 25.(page 103). 
FIGURE 25. CT,FARANCE 03 AS XUAL PARASITAEMIA AND 
TEMPERATURE CHART IN A: _C OF 13.7. (31.- MALARIA 
TREATED 'WITH PAMAQUIN. P'k .ITE STAGES i =° SHO'.TN 
WITH THE COUNT FIGURES. 
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OBSERVATIONS ON THE PHARMACOLOGY OF PAMAQGIiv . 
The results reported above of the effects of 
Pamaquin therapy on the asexual parasite of B.T. 
malaria, indicate that, although generally unrecog- 
nised, it is actually .a powerful schizonticide. This 
property becomes all the more impressive when it is . 
considered that the daily dosage of the drug, (;50.Mgm 
required to produce this effect, is 20 to 30 times 
smaller than the Mepacrine dosage necessary to bring 
about an equivalent destruction of schizonts. When, 
in addition to these findings, it is realised that the 
gametocidal action of Pamaquin is widely accepted, 
and that it has as yet proved the most - effective 
measure in the reduction of the relapse rate in B.T. 
infections, it becomes more and more apparent that 
this drug is indeed 'a potent anti- malarial and one 
well worthy of further investigation into its action. 
The great limitation to the ,extensive use of 
Pamaquin is that it may produce very undesirable toxic 
effects when dosage of more than 40 Mgm is given daily. 
These effects, abdominal-colic, methaemoglobinaemia, 
and more serious degrees of intravascular haemolysis,- 
are well known, and the risk of producing them has 
sually not seemed worth while to clinicians who have 
egarded Pamaquin as being merely a gametocidal:agent. 
n recent years, ho:ever, the value of this drug in 




has lead to its employment on a much wider scale and 
has prompted closer study of its pharmacological pro- 
perties. Most of the latter work has been done with- 
in the past year (1945-46) by Shannon and his colleag- 
ues at the Goldwater Memorial Hospital, New York on 
behalf of the National Research Council of 'America. 
Their results in this investigation, which is still 
continuing, have so far appeared only in restricted 
publication, but it is possible to refer here to some 
of the more interesting findings and to indicate some 
of the lines of promise which might arise from them. 
A chemical technique for the estimation of Pama- 
quin in whole blood, plasma and urine was evolved 
and permitted studies to be made of the absorption, 
utilisation and excretion of this. drug. It was found 
by these means that Pamaquin is absorbed rapidly into 
the blood stream and is removed almost as quickly to 
be stored in the tissues or broken down into degrad- 
ion products. This disposal was suggested by the 
finding that little or no unchanged Pamaquin appears 
in the urine. There seems to be no steady balance 
established between the amounts of the drug present 
in the circulation and the tissues, as is the case 
with Mepacrine, for Pamaquin plasma levels were found 
to vary greatly in relation to times of dosage and 
other factors, and as such were considered to be of 
little value for study as an assessment of the efficacy 
of therapy. Shannon noted that Pamaquin plasma levels 
were/ 
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were consistently higher in subjects who were taking 
Mepacrine as well, and he concluded that the latter 
drug can displace Pamaquin from storage in the body 
tissues, thereby raising its blood level to some 
6 or 8 times that usually found. He suggested that 
this fact may provide the explanation for the apparent 
increase in Pamaquin toxicity when it is given concurr- 
ently with Mepacrine;- a point long recognised by 
clinicians who have had experience of the undesirable 
effects produced in patients by this peculiar form of 
drug incompatability. 
Shannon next investigated the isolation of the 
egradatiun products of Pamaquin as it seemed possible 
hat the anti- malarial activity of the drug was brougit 
bout by one or more of these, rather than by the com- 
ound itself. He was successful in isolating two 
Fractions from the urine of subjects taking Pamaquin. 
raction A was fluorescent, stable and did not appear 
o be toxic, whereas Fraction B was non -fluorescent, 
nstable and highly toxic, causing rapid haemolysis of 
ed blood corpuscles. Considerable variations were 
ound to occur in the quantities of these two products 
xcreted by different patients. 
Information regarding Shannon's findings was 
received in Britain in September 1945 and it was decide 
that it might prove of interest for the Malaria Re- 
search Team to undertake a similar line of investigation 
while 
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while studying the action of Pamaquin on recurrent 
B.T. cases at Woolwich. As a preliminary observation 
it was found possible to demonstrate a fluorescent 
substance in the urine of patients receiving Pamaquin, 
by using the same extraction technique as for urinary 
Mepacrine and by selecting only those patients who had 
taken no Mepacrine for at least 2 months previously. 
The quantities of this substance varied greatly from 
day to day and in different patients and bore little 
apparent relation to the dosage or clearance of para- 
sitaemia. It was, however, absent from the urine of 
control cases being treated on Paludrine. A consid- 
erable delay was occasioned in obtaining the necessary 
reagents and in working out the complicated technique 
for plasma Pamaquin estimations, and by January 1946 
when the author left the Team, this work was only just 
getting under way. It is possible, however, to record 
here some of the plans made for lines of work to be 
followed, which will give an idea of the aims and hopes 
in the field of investigation. 
Interest was centred mainly on the fluorescent 
substance present in the urine of patients taking 
Pamaquin and which was possibly the same as Shannon's 
Fraction A. An attempt was to be made, by passing 
the whole daily urinary output through a chromatographic6, 
absorptive column in ultra- violet light, to isolate 
this fluorescent fraction and to identify its chemical 
nature/ 
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nature. It was hoped that this fraction might prove 
to have anti -malarial properties, and might actually 
represent the non -toxic active principle arising from 
the break -down of Pamaquin. It was also hoped to 
record quantitatively the urinary output of this 
fraction' for comparison with the parasite clearance 
from the peripheral blood, and the subsequent f ollow- 
up record in each case treated with Pamaquin alone, 
or in combination with Paludrine. ( Paludrine is stable 
and non- fluorescent and is excreted unchanged in the 
urine). It would be of great interest to know wheth- 
er the 10 to 15P er. cent of patients who relapse after 
Pamaquin therapy, have shown any difference from the 
other cases in their urinary output of this fluorescent 
factor. 
The toxic urinary product, Shannon's Fraction B, 
is obviously of little interest even though it may 
possess anti- malarial action. Its toxicity and in- 
stability would preclude its use as a drug. Ií, how- 
ever, the stable, non- toxic, fluorescent Fraction A 
could be shown to have anti- malarial activity, espec- 
ially in regard to prevention of relapses in B.T. 
malaria, methods might be found.to increase the f or- 
mation of this degr.dction :.product, from..,.Päms,coin,.given 
in its present dusage. It seems not too much to 
hope that before long, the isolation, analysis and 
eventual synthesis of the active principle derived 
from/ 
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from Pamaquin, may make available in a simple non- 
toxic form an anti- malarial of unique potency. 
110. 
SECTION 3. 
THE ACTION OF PALUDRINE (M.4888) IN THE 
THERAPY OF BENIGN TERTIAN LLARIA. 
The initial trials of Paludrine at Liverpool 
and the subsequent work by Hamilton Fairley in 
Australia, soon established this new drug as being 
an anti -malarial of outstanding importance. In R.T. 
malaria it fulfilled nearly all the criteria of the 
ideal drug, being a true causal prophylactic for the 
prevention of infection and a potent therapeutic 
agent for the cure of the acute attack. In B.T. 
malaria it proved a good suppressant of infection and 
a safe, effective measure for the clinical cure of 
the active phase of the disease. There remained, how- 
ever, the problem of relapsing B.T. malaria in which 
Paludrine did not appear to be as valuable as earlier 
work in chicken seemed to suggest; and also the 
question of its action in resistant Quartan infections, 
about which no controlled therapy trial has yet been 
published. 
The following report deals with the detailed 
action of the drug on the parasites of B.T. malaria 
as studied by the methods of parasite counts and 
microscopic observation previously described. The 
findings are based on 24 active cases treated with 
250 Mgm tablets of Paludrine given twice daily for 
10 days. 
1. CLINICAL RESPONSE/ 
1. CLINICAL RESPONSE. 
All patients tolerated the drug very well in 
the acute, febrile stages and the average duration of 
pyrexia after the start of treatment was 2.0 days, 
being the same as in the control series treated with 
Quinine plus Pamaquin. Patients were allowed up 
after they had been afebrile for 48 hours. In 5 
cases there were mild complaints of nausea and slight 
epigastric discomfort within a few minutes of swallow- 
ing the early morning tablet from the 5th to 7th days 
ofthe course. These symptoms were easily prevented 
by giving the tablet after food, or with a full half 
pint of water, or with a small dose of an alkaline 
mixture. Patients who experienced these slight 
manifestations of direct gastric irritation in the 
- middle of the course, had no complaints during the 
later days of dosage. In no case did the drug have 
to be stopped owing to intolerance, and daily blood 
and urine examinations revealed no indication of 
toxic effects. 
The general impression formed was that Paludrine 
was clinically in every way satisfactory in the treat - 
ment of the acute malarial attack. 
2. CLEARANCE OF ASEXUAL PARASITAEMIA. 
The average duration of treatment required to 
clear asexual parasites from the peripheral blood 
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FIGURES 26,27.(page 112). 
FIGURE 26. CLEARANCE RATE OF ASEXUAL 
PARASITAEMIA ON PALUDRINE THERAPY (24 ET CASES) 
Paludrine cases. 
{ 
control QP cases. 
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FIGURES 28,29.(page 112). 
FIGURE 28. 
PALIIDRITE THERAPY 
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control Quinine- Pamaquin cases. 
Figure 26 shows in graphic form the fall -off in 
the daily asexual parasites, and Figure 27 indicates 
the percentage number of cases in which asexual para- 
sites were present on each day of treatment. 
3. CLEARANCE OF GAMETOCYTES. 
Figure 28 shows the average gametocyte counts 
plotted at 24 hour intervals from the start of ther- 
apy and in Figure 29, the percentage number of cases 
is recorded in which sexual parasites were present 
initially and on each of the first 8 days of the 
course. 
It will be seen that B.T. gametocytes may per- 
sist in blood films up to one week after the start 
of Paludrine, a time which compares unfavourably 
with the gametocyte clearance -time of any of the 
other anti- malárials studied. The persistent forms 
of gametocyte were all observed to be females. It 
is of interest to recall, in this connection, that 
the large fully -grown female gametocyte probably 
represents a non- feeding stage of the parasite and 
as such would be unlikely to be much affected by a 
drug which had to be ingested to produce its action. 
4. EFFECTS ON THE DEVELOPMENT OF THE 
B.T. ASEXUAL CYCLE. 
Inhibition of trophozoite maturation is seen 
with Paludrine, but occurs later than when Mepacrine, 
Quinine, or Pamaquin is used for treatment. There 
is/ 
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is thus a slightly longer latent period with Paludrine 
than than with these other drugs between the time of 
administration and the first visible effects on 
parasite development. 
Patients who start treatment with young tropho- 
zoites do not as a rule eradicate their asexual 
parasites until the stage of segmenting trophozoites 
is reached. The biggest disappearance occurs mainly 
after the latter stage. If inhibition of develop- 
ment takes place before the parasites can reach this 
. stage, then much longer persistence results. This 
finding is not peculiar to Paludrine alone, but has 
been observed with all the other anti -malarials 
studied. 
Patients who start treatment with late tropho- 
zoites in.the blood stream, show a much more rapid 
parasite clearance, as segmentation of the nucleus 
has occurred before the inhibitive effect on develop- 
ment has had time to prevent the parasites from reach 
ing the highly susceptible schizont stages. The 
drug appears to have a destructive effect on earlier 
forms of schizonts, (S 1 S 2), than any of the other 
anti -malarials, which attack later schizonts, mero- 
cytes, and in the case of Quinine, the merozoite- 
young trophozoite transition stage. 
5. MORPHOLOGICAL Et+'FECTS ON THE ASEXUAL PARASIT 
Collapse of the amoeboid forms of trophozoites 
occurs/ 
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occurs with Paludrine, though this effect is later 
and less complete than that produced by Mepacrine. 
The action resembles that of Pamaquin in this 
respect. 
The malarial pigment present in late tropho- 
zoites becomes coarsely granular with Paludrine 
therapy. It is not bunched together or extruded as 
with Mepacrine and Pamaquin. 
There appears to be a powerful interference with 
the dividing chromatin nucleus during Paludrine ad- 
ministration, and this occurs in a more striking 
. manner than has been seen with any of the other drugs 
studied. The differentiation of the chromatin of 
the segmenting trophozoite into numerous rod -like 
structures,' occurs in the normal manner, but instead 
of these re- grouping to form two distinct nuclei, the 
chromatin remains in this differentiated phase appar- 
ently inhibited from further development. Parasite 
fords showing this unusual state of nuclear chromatin 
arrest are produced, sometimes in large numbers, and 
are seen to persist for long past the time when they 
should normally have undergone complete schizogo4y. 
These are not uncommonly the last forms of asexual 
parasites to be found in the peripheral blood during 
Paludrine therapy. It proved only possible to 
distinguish these damaged nuclear types in thin blood 
smears, as in thick films they appear closely similar 
to/ 
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to female B.T. gametocytes which as noted, are them- 
selves unduly persistent during Paludrine treatment. 
This point of differentiation is one likely to cause 
considerable difficulty in enumerating B.T. asexual 
parasites in tin blood of cases receiving this drug. 
A general effect, seen late in Paludrine therapy, 
is that B.T. asexual parasites in various stages of 
degeneration are found, with fading cytoplasmic stain- 
ing and indistinct chromatin. These degenerate forms 
may occur at any phase in tie developmental cycle and 
are more commonly seen with this drug than with Quin - 
ine, Mepacrine or Pamaquin. Parasites thus affected, 
may fade quietly out of the blood picture without 
showing any gross morphological changes. 
COMBINED THERAPY iiu7ITH PALUDRINE 
AND PAMAQUIN. 
The idea of combining Paludrine and Pamaquin 
in a therapy course arose when it was found that a 
disappointing high proportion of B.T. cases treated 
with Paludrine alone had further recurrences. In 
preliminary follow -up estimates of such cases, the 
relapse rate was in the region of 30 per cent, being 
as high as with Mepacrine therapy. This finding 
again pointed to the inadvisability of drawing too 
close/ 
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close an analogy between human and chicken malaria 
infections, as in the latter Paludrine in non -toxic 
doses, had proved much more effective in suppressing 
the tissue phases of the parasites than had heavy 
toxic dosage with Pamaquin. 
It was thought that it might be of interest and 
value to try the effect of Paludrine and Pamaquin 
together in human malaria, as the new drug was a 
stable product, quite unrelated to Pamaquin in 
chemical structure, and might possibly produce an 
additive effect in the form of a combined assault on 
the resistant tissue forms of parasite that are 
believed responsible for recurrences of the infection. 
Remembering Shannon's finding that Mepacrine 
could displace Pamaquin from the tissues and so pro- 
duce toxic levels. in the circulation, it was realised 
that a similar displacement might result when giving 
Paludrine and Pamaquin together. Accordingly pre- 
liminary trials of the combined dosage were made in 
chicken and animals by Dr. D.G. Davey of Imperial 
Chemical (Pharmaceuticals) Ltd., and only when these 
showed no obvious effects, was similar work begun by 
the Malaria Research Team on patients at Woolwich. 
The first cases to receive this treatment were 
given simultaneous doses of Pamaquin, 10 Mgm and 
Paludrine 50 Mgm twice daily. Both drugs were given 
in tablet form and administration was continued for 
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10 days. No ill -effects were noted and after 6 
patients had completed the course without toxic 
manifestations, the dosage was increased to thrice 
daily. It was decided not to give more than 30 Mgm 
of Pamaquin each day and so succeeding groups of cases 
were given gradually increasing doses of Paludrine 
added to the constant amounts of Pamaquin. By these 
means it was found possible to work up the combined 
dosage to 30 Mgm Pamaquin plus 750 Mgm Paludrine per 
diem, for a course of 10 days. Careful clinical and 
laboratory observation revealed no signs of drug- 
. intolerance other than the occasional 5th to 7th day 
slight gastric irritation which occurs with Paludrine 
alone, and mild cyanosis noted in one patient from 
the 5th day of treatment. 
It was agreed to treat a series of 100 or more 
cases on this therapy regime and to compare the 6 
month follow -up results with those of the control 
series receiving Quinine and Pamaquin. By January 
1946, insufficient cases had been treated to allow 
time for such a follow -up, but it is of interest to 
record that while cases were being re- admitted to 
hospital with recurrences following treatment with 
Paludrine alone, there had then been no relapses 
reported amongst the patients who had been treated 
in the various trial groups receiving increasing 
doses of the combined therapy. 
As regards the effects of Paludrine and Pamaquin 
together/ 
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together on the parasites of B.T. malaria, no especial 
ly rapid clearance of parasitaemia was found to re- 
sult. The average duration of asexual parasitaemia 
after the start of treatment was 1.7 days in the 
first 26 cases receiving the highest dosage course. 
It was noted that with Pamaquin being given, the 
gametocytes were cleared much more rapidly than with 
Paludrine alone. 
The investigation of this combined course also 
included estimations of the plasma concentrations of 
Pamaquin and Paludrine, but the findings in this 
. work are at present incomplete. It is sufficient 
here however, to have drawn attention to the proof 
that it is a practicable measure to combine Paludrine 
with Pamaquin in the treatment of B.T. malaria and 
to record that such therapy would appear to constitute 
a rational approach to the problem of minimising 
recurrences of this T1nuisance" infection. 
PART THREE. 
A STUDY OF THE STAINING OF MALARIA 
PARASITES IN THICK BLOOD FILMS 'aITH A 
DESCRIPTION OF A MODIFICATION OF FIELD'S 
STAINING METHOD. 
119. 
At the outset of the work on malaria therapeutic 
research, it was realised that the staining method 
employed for the demonstration of malaria parasites 
in thick blood films used for parasite counts would 
be of great importance in attaining reliable results. 
It appeared also that with such a large number of 
films to be examined, a rapid staining technique 
such as that introduced by J.W. Field in 1941 (Trans. 
'Roy. Soc. Trop. Med. Hyg., 35, 1, 35 -42), would save 
a great deal of time as compared with other methods. 
Accordingly a study was made of the merits of Field's 
and other staining techniques and from observations 
and experiments made in the course of this investigat- 
ion, it was found possible to produce a modification 
of Field's method which ensured that optimal staining 
was more regularly achieved. It is intended to de- 
scribe here some of the main points of this work and 
to give details for the preparation and use of the new 
stain. A short description of the latter was publish 
ed in September 1945; "A Staining Method for Malaria 
Parasites in Thick Blood Films' by J.C.B. Fenton and 
James Innes, Trans. Roy. Soc. Trop. Med. Hyg., 39, 1 
S7 -90) . In the following report, a knowledge of 
Field's and other methods of staining thick blood 
films/ 
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_films will be assumed. 
Dilute Romanowsky stains, such as Giemsa stain 
have been used for many years for the demonstration 
of malaria parasites in thick blood films. Provid- 
ing that they are not excessively thick, the films do 
not need to conform to any definite specifications 
and lose most of their haemoglobin whilst staining. 
The malaria parasites and leucocytes are thus seen 
against a clear white background and on one plane of 
focus. many workers prefer such a dehaemoglobinised 
background to the darker pink background that is seen 
with Field's staining method. 
The main disadvantages of the dilute Romanowsky 
stains are that they tend to cause distortion of the 
leucocytes and their staining qualities are very 
sensitive to small changes in the pH values of the 
water diluent. Thus variable results are sometimes 
recorded, particularly with Leishrnan stain which varies 
in its staining power from batch to batch, and under 
field conditions the necessary staining corrections to 
adjust these variations are not always easy to apply. 
Field's isotonic Methylene- Blue -Azure and Eosin 
stain has a great advantage over thick blood film 
stains in the speed and ease of its method of use. 
Its early widespread adoption by a great many patholo- 
gists indicated the real need that existed for a 
reliable rapid staining method for malaria diagnosis. 
Its/ 
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Its introduction implied a great saving of time in 
busy laboratories with many films to examine and the 
relatively minor disadvantages in the method were 
outweighed by the advantage gained in the time factor. 
One disadvantage of Field's method is that the 
blood films stained must be somewhat thinner than 
those used with the dilute Romanowsky stains and the 
films must be made to conform with certain specificat- 
ions of size. Furthermore, although the staining 
properties of Field's stain solutions are fairly con- 
stant, very careful attention to the correct staining 
times are necessary to produce consistent results. 
While this presents no problems when dealing with 
thick films properly made and intended for staining 
by the rapid method, experience shows that blood films 
are frequently received for examination that are 
impossible to stain correctly on account of being far 
too thick or too small and thin. Occasionally even 
with properly made films, one f nds that only certain 
parts of the film, lying between the extremes of red 
and blue, are correctly stained. 
A common mistake in staining a. badly made thick 
film by Field's method, is to overstain in the Eosin 
solution. Once this has been done, the resultant 
faulty staining cannot be corrected by returning the 
slide to the Methylene -Blue -Azure solution. It was 
found that in such cases of overstaining in the Eosin, 
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the fault could be easily corrected by a gentle rins- 
ing of the slide in a very dilute Leishman stain. 
Furthermore, the result of staining a slide in this 
manner appeared much superior to that obtained by 
staining with the usual Field's technique. It was 
also found that by allowing the slide to'stand in the 
dilute Leishman stain until it becomes transparent, 
complete dehaemoglobinisation of the film took place 
with no loss of the stain from the leucocytes or 
malaria parasites if present. 
It would seem that, used as above described, 
dilute Leishman stain can be made to act as a correct- 
ive and differentiating agent of Field's stain, there- 
by greatly enhancing the staining qualities of this 
method. In the dilution employed, the Leishman stain 
itself is too weak to take part in the direct staining 
of the film, but acts in conjunction with the Methy- 
lene-Blue-Azure and Eosin solutions both of which form 
necessary constituents of the stain. Blood films 
immersed in either of the latter solutions alone and 
then washed in the dilute Leishman do not give satis- 
factory results. 
Having recognised the superior staining propertied 
of this combined Field -Leishman stain, an investigat- 
ion was made to determine the optimum conditions for 
the staining of malaria parasites in thick films using 
this method. This involved mainly a ,study of the. 
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staining effects produced by varying the pH value of 
the solutions of Methylene -Blue- Eosin, Azure 1 and the 
dilute Leishman stain. This work, conducted on a 
"triai and errors basis with a large number of variat- 
ions in the formula of the combined stain, brought to 
light the many complicating difficulties liable to 
offset the desireü result, and served to emphasise the 
extreme importance of the correct pH values in the 
various stain solutions. For instance, it was found 
that the clearest differential staining of the parasit 
with Methylebe -Blue and Eosin occurred at a pH of 7.4, 
but at this same pH, the other component of the stain, 
Azure 1, stained and mordanted the fibrin threads and 
red cell envelopes comprising the basis of the film 
and so gave rise to a highly coloured red background. 
The results obtained, in this study of the stain- 
ing properties of the individual stains in acid and 
alkaline solution, may be briefly summarised as 
follows: 
1.Methylene Blue. 
(a) In -acid solution (pH approximately 6.0) 
No affinity for red cell envelopes, slight 
affinity for parasite chromatin and moderate 
affinity for parasite cytoplasm. 
(b) In alkaline solution (pH approximately 7.6) 
Great affinity for red cell envelopes and 






In acid solution (pH approximately 6.0) 
Very great affinity for red cell envelope 
and parasite chromatin. Slight affinity for 
parasite cytoplasm stained with Methylene -Blue. 
This results in a partial decolourisation which 
tends to destroy the sharp contrast between the 
red chromatin and blue cytoplasm. 
(b) In alkaline solution (pH approximately 7. ) 
Marked affinity for haemoglobin and 
parasite chromatin. 
.Azure 1. 
(a) In acid solution (pH approximately 6.0) 
Slight affinity for red cell envelopes 
and blood platelets, with moderate affinity for 
Schuffner's dots and parasite chromatin. 
(b) In alkaline solution (pH approximately 7.6) 
Very great affinity for red cell envelopes 
fibrin threads, parasite chromatin, Schuffnerts 
dots and blood platelets. 
The staining activity of Azure solutions 
appears to be affected by changes in temperature, 
being much increased in warm weather. 
From the above experiments it was concluded that 
the optimum pH value for the staining of malaria 
parasites in thick films lay between pH 6.6 and pH 7.0. 
At this range the more common background debris such 
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as fibrin threads and red cell envelopes are least 
conspicuous. It was also apparent that the exact 
optimum pH was dependent upon the degree of dehaemoglo- 
binisation of the film and that this factor was of 
great importance in determining the final appearance 
of the stained film. 
A film :ihich contains free haemoglobin after 
staining has a tendency to turn blue during drying. 
This may be due to a change in pH towards alkalinity 
which occurs by reason of-the buffering power of the 
haemoglobin protein. Under such conditions, Eosin 
would be absorbed by the residual haemoglobin and a 
blue colouration of the film would result. This 
effect can be avoided by one or two procedures, namely ' 
staining with Eosin to an excess, or by staining at a 
pH slightly more acid than the optimum. If on the 
other hand the blood film contains no free haemoglobin, 
the optimum pH for .staining was found to be pH 6.8 to 
6.9. 
In the new stain described here, the pH optimum 
of 6.8 has been-chosen in order to allow for a very 
small amount of residual haemoglobin such as is usual- 
ly left in the blood film after staining. Further- 
more, the final staining and dehaemoglobinising 
solution contains a small amount of phosphate buffer, 
and since the slide is taken out of this solution 
and allowed to dry without further washing, the buffer 
that is left on the film acts as an additional control 
to mimimise changes in pH. 
The/ 
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The following are the directions for she preparat- 
ion and use of the modified stain: 
PREPARATION. 
There are three staining solutions -A, B and C: 
A being the Methlylene -Blue Azure solution, B the 
Eosin stain, and C a corrective Leishman solution. 
Stain A. Is made from a mixture of two solut- 
ions which should be prepared separately.. 
Solution (1) Methylene -Blue ... .... ... 1 gramme 
Disodium hydrogen 
phosphate (12 H20) .. ... 5 gramme 
Distilled water .. ... ..250 c.c. 
Place this aoiution in a 500 c.c. conical flask 
and immerse in a bath of boiling water for 2 hours 
15 minutes. The neck of the flask should not be 
plugged, but allowed to have:_free access to the air, 
as the formation of azure depends on the oxidization 
of alkaline Methylene -Blue by the atmospheric oxygen. 
If the azure is prepared under these conditions, the 
right proportion of azure in relation to the Methy- 
lene Blue will be formed. Azure made by this poly - 
chromizing method has been found more satisfactory 
for staining than pure Azure i added to Methylene - 
blue in the preparation of this stain. The poly - 
chromizing should not be carried on beyond the stated 
time or too much azure, will be formed, and too much 
is almost as bad as too little. If the azure is in 
excess, then fibrin threads will stain in the back- 
ground/ 
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ground of the films, the parasite cytoplasm will not 
stain a good blue colour and the parasite chromatin 
may appear black. 
A heavy deposit may separate out when the solut- 
ion is heated and the flask should be set aside, say 
overnight, to allow this to re- dissolve. When cold, 
the solution should be made up to its original volume 
and should' appear a purple blue cólour when viewed in 
artificial light. Too much azure production results 
in á more reddish purple colour. 
Solution (11) Methylene -Blue ... ... ... 1 gramme. 
Potassium dihydrogen 
phosphate . ... ... ... 2 grammes 
Distilled water .. ... ..500 c.c. 
To prepare Stain A, add two parts of Solution (11) 
to one part of Solution (1). This method of prepar- 
ation ensures that there is always some unchanged 
Methylene -Blue present in Stain A rather than a mix- 
ture of poly- chromed by- products. 
Stain B. Yellow water soluble cosin 1 gramme. 
Disodium hydrogen 
phosphate (12 H2O .... 3.3 gramme 
Potassium dihydrogen 
phosphate ... ... 1.3 grammes. 
Distilled water 500 c.c. 




Stain C. A stock buffer solution is required to 
prepare this stain, and consists of:- 
Disodium hydrogen phosphate 
(12 H20) 12.5 grammes 
Potassium dihydrogen 
phosphate ... ... ... ... ...5 grammes. 
Distilled water... ... ... 250 c.c. 
Ether, 0.5 to 1.0 c.c., may be added to preserve 
this solution from bacterial contamination. 
The stock buffer solution should have a pH value 
of approximately 6.8. This should be checked with an 
indicator if there is any reason to suspect that the 
sodium phosphate has lost some of its water of crystall 
isation. 
To prepare the corrective Leishman stain, make a 
1 in 50 dilution in distilled water of ordinary 0.15 
per cent. Leishman stain, and add the stock buffer 
solution at the rate of three parts in 100 of the 
total mixture. 
METHOD OF USE. 
The staining times for a thick blood film are 
recommended as follows, although these can be varied 
a great deal without producing an adverse result: 
1. Dip in Stain A for 1 to 2 seconds. 
2. Wash in distilled water for 1 second. 
3. Dip in stain B for 2 to 3 seconds. 
4. Wash in distilled water for 1 second. 
5. Place in stain C for 10 to 15 minutes in 
a small staining dish. 
The/ 
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The slide should be taken out of the Leishman 
stain and stood upright to dry without further washing 
in water. 
NOTES ON THICK FILMS STAINED AS AHUVE. 
1. No definite specifications as to size or 
thickness of the blood film need be laid down for 
staining by this method. The films can be much 
thicker than those recommended for use with Field's 
. technique as dehaemoglobinisat.ion occurs as in the 
dilute Romanowsky staining method. 
2. The naked eye appearance of a successfully 
stained film is that it should be completely' trans- 
parent and without any residual haemoglobin. The 
colour should be a very faint purple blue. 
3. After staining, the film may be dried in an 
incubator if desired, but like other Romanowsky stains, 
if dried by direct heat it will turn blue. 
4. No harm is done by leaving films for much 
longer than the specified'l0 to 15 minutes in the 
dilute Leishman stain. In very thick films such 
longer time will produce better results by ensuring 
complete dehaemoglobin. sat ó 
5. Films that turn blue on drying have either 
(a) not been completely freed of haemoglobin 
and should have been left longer in 
the Leishman stain;' or 
(b) have been differentiated in a Leishman 
stain more alkaline than pH 6.8. 
6./ 
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6. Films that have an excessively red appear - 
have been differentiated in a Leishman 
stain more acid than pH 6.8. 
THE MICROSCOPICAL APPEARANCES OF A 
SUCCESSFULLY STAINED THICK FILL. 
The Stained leucocytes, platelets and malaria 
parasites are contrasted against a clear white back- 
ground, thus resembling in general a film well stained 
by dilute Giemsa. Since the Methylene -Blue -Azure 
solution A has a mild fixative action, there is little 
or no distortion of the leucocytes. The granules of 
the cytoplasm of the polymorphonuclear cells are often 
powerfully stained. In Plasmodium vivax infections 
the Schuffner1s dots usually stain intensely in the 
thinner parts of the film. This gives rise to the 
"ghost Cell" effect that is seen also with Giemsa 
stain and when present forms a diagnostic indication 
of the benign tertian parasite that mey be most valuab- 
le evidence in a case where young ring forms are seen 
only in the film. 
The parasite cytoplasm is stained a blue or grey - 
blue colour and fine details in its structure can often 
be seen. The parasite chromatin stains a deep red. 
In experiments to determine the maximum thickness 
of film stainable by this method, films up to 1 milli- 
metre in thickness were satisfactorily stained. The 
only modification in technique required for staining 
these, was a slightly langer immersion of the slide 
in/ 
131. 
in Stain..C. than the time of 10 to 15 minutes recommen- 
ded for routine films. In such ultra -thick blood 
films, between 60 and 80 leucocytes are seen per oil 
immersion microscope field in blood with a normal total 
white -cell count; and whereas preparations of this 
nature are of experimental interest only, they do 
indicate the very high diagnostic capability of the 
thick -film method when a suitable dehaemoglobinising 
stain is employed. Since the rate at which dehaemo- 
globinization occurs is increased by a rise in temper- 
ature, it is usually possible to stain thicker blood 
films more easily during warm weather. 
The above staining method was used on several 
thousand thick films taken for routine diagnostic and 
research purposes and was found to give consistently 
successful results. It proved of especial value in 
the estimation of parasite counts, as the thickness 
of the films made it possible to count small numbers 
of parasites as they diminished following the start 
of treatment; and also in the many, tedious hours 
of microscope work involved in this investigation, it 
was a great advantage to be looking at parasites and 
leucocytes in dehaemoglobinised films rather than 
against the pink background of Field's stain preparat- 
ions. The method was adopted by the laboratories of 
several of the military hospitals working in Italy 
and/ 
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and the pathologists who tried it reported favourably 
upon the results obtained which, they agreed, were 
such as to increase considerably the chances of find- 
ing malaria parasites in cases with only a scanty 
parasitaemia. It is hoped that this modification 
of Field's stain may prove of some value to those for 
whom malaria diagnosis is ari important part of their 




i Ai'd FOUR. 
GENERAL CONCLUSIONS. 
It is fitting that the last part of this thesis 
should draw attention to the main points of interest 
which it would appear reasonable to extract from the 
mass of results and theoretical argument making up the 
subject matter of the foregoing pages. It is intend- 
ed to present these conclusions in a general way with 
reference to their supporting evidence, practical appli 
ation and scientific interest, and it is hoped that in 
this manner it will be possible to set forth in a few 
pages, some angles on malaria chemotherapy that may be 
of value to both the clinician and the laboratory 
worker. The conclusions are considered under numbered 
headings as they deal with different aspects of the 
work reported, and as such do not form an entirely 
continuous sequence. 
1. THE THERAPEUTIC TRIAL OF ANTI -MALARIAL 
DRUGS. 
The assessment of the therapeutic value of an 
anti -malarial compound should be based on a wide series 
of observations covering the following investigations. 
These are:- (a) its toxicity in both therapeutic 
and prolonged suppressive doses and its compatibility 
with other drugs, (b) its speed of action in clearing 
asexual parasitaemia as estimated by parasite counts 
-recorded/ 
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recorded at regular intervals from the start of treat- 
ment, (c) its detailed mode of action on the asexual 
cycle of different varieties and strains of human 
malaria infections, (d) its possible action on tissue 
phases of the parasites both in regard to causal prop- 
hylaxis of primary mosquito infections, and in its 
effectiveness in influencing the relapse rate of 
established infections, (e) its fate in the body, 
absorption, utilisation, storage and excretion, and 
(f) its effect on gametocytes. 
2. PARASITE COUNTS AND STAINING. 
Parasite counts form an important part of a 
controlled therapeutic trial, but require a skilled 
and highly efficient technique if their interpretation 
is to be of real value. They are best done in thick 
blood films in which the parasites are counted in 
proportion to the leucocytes and their number per.,cubic 
millimetre calculated from the white blood cell counts. 
Very thick blood films are needed to detect the scanty 
parasitaemia seen as treatment progresses, and Optimal 
staining of such films is an essential, with dehaemo- 
globinisation a great advantage. 
An investigation into the staining characteristic 
of malaria parasites in thick blood films showed the 
pH of the staining solutions to be the determining 
factor in the production of good results. It was 
possible from these experiments to introduce a 
modification/ 
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modification of Field's staining technique which has 
been used with success in the parasite counts reported 
throughout this thesis. 
3. FINDINGS IN M.T. INFECTIONS AND 
STERNAL MARROW EXAMINATION. 
Only a very limited number of cases with M.T. 
malaria were available for study, but it was possible 
to make certain observations from the results of 
parasite counts done at 12 hour intervals during the 
treatment of this small series. Such counts suggest- 
ed that the clinical peak of pyrexia would be the best 
time for the diagnostic demonstration of parasites 
in the peripheral blood and would be also the optimum 
time for the start of parentera1 therapy with Quinine 
or Mepacrine. 
Examination of sternal marrow smears in 52 cases 
of B.T. and M.T. malaria showed that parasites were 
found no more frequently in this site than in thick 
films of the peripheral blood. It was possible, how- 
ever, to demonstrate M.T. gametocytes in the marrow 
about 3 days before they were detected in blood films, 
suggesting, that these sexual forms are developed 
from visceral rather than from circulating parasites. 
No evidence was found in the marrow of any extra - 
erythrocytic phase of parasites. 
4. COMMENTS ON THE TREATMENT OF B.T. FRESH 
AND RELAPSE CASES IN THERAPEUTIC TRIAL 
IN C.M.F. 
(a) The clearance of asexual parasitaemia in 
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Fresh cases was found to occur more rapidly than with 
low oral Mepacrine dosage, and both of these were 
quicker than dosage with Quinine. 
(b) In Relapse cases there was no significant 
difference between the rate of clearahce of asexual 
parasites with heavy oral Mepacrine and with Quinine 
plus Pamaquin. 
(c) Quinine and Quinine plus Pamaquin were 
both more effective than Mepacrine dosage in clear- 
ing gametocytes from the peripheral blood in both 
Fresh and Relapse infections. With low Mepacrine 
dosage, in some Fresh cases, the female gametocytes 
were able to persist beyond the last day of the 
treatment course. 
(d) On a 6- month follow -up, relapses were 
fewer after all the courses which had contained Pama- 
quin. Although the small numbers of Fresh cases 
treated on each therapy course mean-b.-that the follow - 
up figures showed little significance when analysed 
statistically, on the larger series of Relapse cases, 
the advantage of Pamaquin in preventing B.T. recurr- 
ences was significantly demonstrated. 
The above findings show that in the routine 
treatment of B.T. infections,. dosage with Mepacrine 
should be initiated as early as possible, as this 
drug produces the most rapid effect in the reduction 
of the asexual parasitaemia. It was therefore 
recommended/ 
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recommended that a standard therapy course for malaria 
cases in C.M.F. in 1945 should contain Mepacrine dosag 
earlier than had been hitherto employed. It was con- 
sidered necessary to leave Quinine as the treatment on 
the first day of the course to allow for M.T. ixsect- 
ions, in which it was felt that Quinine is a better 
drug in the control of initial pyrexia and general 
symptoms. Three days pif Quinine and Pamaquin dosage 
were also recommended ap the end of the course, both 
for the value of Pamaquin in reducing the tendency to 
B.T. relapses, and for its gametocidal action. 
The following are particulars of the dosage 
suggested for an 8 -day standard treatment suitable 
for all fresh and relapse cases of B.T. and M.T. 
malaria. 
Day Drugs & Dosage. 
1. Quinine 10 grains, 3 doses, 8 hourly. 
2. Mepacrine 0.2 gm, 4 doses, 6 hourly. 
3. Mepacrine 0.2 gm, 4 doses, 6 hourly. 
4. Mepacrine 0.2 gm, 3 doses, 8 hourly. 
5. Mepacrine 0.2 gm, 3 doses, 8 hourly. 
6. Quinine 10 gr & Pamaquin 0.01gm, 3 doses, 8 hourly. 
7. Quinine 10 gr & Pamaquin 0.01gm, 3 doses, 8 hourly. 
8. Quinine 10 gr & Pamaquin 0.01gm, 3 doses, 8 hourly. 
Totals. Quinine 120 grains. 
Mepacrine 2.8 gm. 
Pamaquin 0.09 gm. 
In/ 
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In patients with B.T: infections who had had 
multiple recurrences, it was suggested that a further 
4 days of Quinine and Pamaquin dosage could be added 
at the end of the course. 
5. . THE ANTI- MALARIAL EFFECTS OF PAMAQUIN. 
The action of Pamaquin in the treatment of B.T. 
malaria had been studied in detail, as it appears that 
future work on the pharmacology of this drug may lead 
to important advances in malaria chemotherapy. 
Contrary to general opinion, Pamaquin has been 
shown to exert a delayed but powerful schizonticidal 
action in the clearance of asexual parasitaemia in 
B.T. infections. This action is quite apart from its 
gametocidal effects which are recognised to be more 
active than those of other drugs. It seems likely 
that after absorption, Pamaquin is broken down in the 
body yielding degradation products, some of which are 
toxic substances, but others being potent anti -malaria 
factors with an action against resistant, tissue phase 
of parasites as well as against the demonstrable 
blood forms. Work is proceeding in an attempt to 
isolate the active, non -toxic products which might 
prove of great value in the treatment of recurrent 
malaria. 
This thesis contains 6- month follow -up records 
of 424 cases of B.T. malaria, which includes cases 
treated for Fresh, Relapse and Multiple Relapse 
infections/ 
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infections. Of this number, 202 received treatment 
containing Pamaquin dosage of 3 to 20 days duration 
as part of various therapy courses which also con- 
tained Quinine and Mepacrine. The other 222 cases 
received from 7 to 20 days treatment with Quinine and/ 
or Mepacrine, but were given no Pamaquin. The sub- 
sequent relapse rate in these two comparable groups 







RELAPSE 57 18 
NO RELAPSE 165 131 
The above results are statistically highly 
significant in showing the influence of Pamaquin on 
the relapse rate in B.T. infections, (Chi -square 
19.26 with Probability less than 0.001.) 
Another follow -up of interest was in the group 
of 50 cases, treated for multiple recurrences of 
B.T. malaria, where no further relapses were recorded 
after Quinine plus Pamaquin therapy given intermitt- 
s 
ently over a period of 30 days. The reáons for the 
unique success of this treatment regime are not easy 
to postulate, but it is known that early recrudescenc- 
es are the common form of relapse after Quinine and 
Pamaquin therapy, and it is therefore possible that 
an intermittent course would be more successful than 
a/ 
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a continuous course in dealing with an infection which 
tended to remain inhibited in some latent and resistant 
form during the administration of anti -malarial drugs. 
It should be noted in this connection, that both Quin- 
ine and Pamaquin are fairly quickly excreted from the 
body and any such inhibition exerted by them would thus 
be soon removed during the intervals in the treatment 
course, whereas with a slowly excreted drug like 
Mepacrine, any action on latent parasite forms would 
tend to be much more sustained. 
It must be mentioned that other recent workers 
have not always reported similar favourable results 
with Quinine -Pamaquin therapy. A therapeutic trial 
conducted on 384 British cases of chronic B.T. malaria 
in Southern India Command in 1945, yielded a 34.2% 
relapse rate after a 10 -day Quinine plus Pamaquin 
course, within a follow -up period of 3 months. The 
peak incidence of relapses occurred in the third week 
after treatment, which is in keeping with the observat- 
ion to this effect made above, but the difference in 
the results is not easy to explain. Much of the 
original work which drew attention to the anti- relapse 
value of Pamaquin was carried out in India by Sinton, 
and in the recurrent B.T. cases from India treated by 
the Research Team at Woolwich during the Autumn of 
1945, the 10 -day Quinine- Pamaquin course appeared to 
be producing results comparable with those in the 
--- earlier/ 
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earlier C.M.F. cases with a relapse rate much lower 
than 30%. One point which may have influenced the 
different findings, is that the patients in C.L.F. 
and at Woolwich were mostly treated during the winter 
months and were not taking suppressive Mepacrine just 
before the clinical attack. In view of the property 
of Mepacrine to displace Pamaquin from the body tissues 
.it is possible that the question of previous suppress- 
ive Mepacrine is an important factor which must be 
taken into consideration when assessing the relapse 
incidence of B.T. infections treated on Pamaquin 
therapy. 
6. THE ACTION OF PALUDRIIVE (M.4888) 
III B.T. MALARIA. 
Therapeutic trials with this new drug are still 
in progress, but from the results so far obtained, 
it promises to be the greatest advance in malaria 
chemotherapy yet made. In M.T. malaria, Hamilton 
Fairley has found it to be a true causal prophylactic 
against natural infections and therefore ideal for the 
prevention of this disease. It is also highly succes 
ful in the treatment of clinical attacks of M.T. 
malaria. In B.T. malaria, while not a causal pro- 
phylactic, it is a good suppressive drug, being easy 
and safe to administer over long periods. It is also 
effective in the treatment of acute B.T. attacks, 
although it does not prevent the tendency to relapse. 
Its action in Quartan malaria has not yet been reporte. 
It/ 
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It seems likely that in the near future, Paludrine 
will entirely supersede Mepacrine for the routine pro- 
phylaxis, suppression and treatment of M.T. and B.T. 
malaria. 
This thesis reports the first trial of Paludrin 
in which detailed observations were made of its action 
on B.T. parasites during treatment. It has been sho- 
that it brings about clearance of asexual parasitaernia 
in approximately the same time as taken by Quinine 
or Mepacrine, though there is a rather longer latent 
period before its initial effects than with these 
drugs. It produces an inhibition in the development 
of growing trophozoites similar to that seen with 
other anti -malarials, but it causes an arrest of the 
parasites at the stage of their first nuclear division 
Schizonts of an earlier form are destroyed by this 
drug than is the case with Quinine, Mepacrine and 
Pamaquin and the optimum rate of clearance of asexual 
parasites occurs when the administration of the drug 
is started on the day following the clinical paroxysm. 
Paludrine does not appear to have a powerful action 
on L.T. gametocytes. 
It has been shown that Paludrine in adequate 
therapeutic doses can be safely given at the same time 
as Pamaquin. In this respect it has advantages over 
Mepacrine which is pharmacologically incompatible with 
Pamaquin, and it is hoped that combined Paludrine- 
Pamaquin/ 
TABT,F 11.(page 143). 
THERAPEUTIC 
PROPERTY. QUIN . 
DRUGS. 
MEP. PAM. PALUD. 
Usual daily 
dosage. 2.0 gm. 0.8 gm. 0.03 gm. 0.75 gm. 
Toxicity. ++ + + + ++ + 
Speed of initial 
action. + + ++ + ++ + ++ 
Reduction of 
pyrexia. + + ++ + ++ + + ++ 
Inhibition of 
parasite cycle. + + ++ + ++ + ++ (latej ++ 
Parasite stages 
destroyed. M - T 1 S2S3MT1 S3 M T6S1S2 
Rate of Asexual 
clearance. + ++ + + ++ ++ + ++ 
Collapse of 
amoeboid forms. - + + ++ ++ + 
Bunching of 
pigment. - + + ++ ++ + 
Action on 
Gametocytes, + ++ ++ + + ++ + 
Reduction of 
relapses. + ++ + + ++ ++ 
TABLE 11. A COMPARISON OF SOME PROPERTIES AND 
EFFECTS OF QUININE, MEPACRINE, PAMAQUIN AND 
PALUDRINE IN THE TREATMENT OF B.T. MALARIA. 
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Pamaquin dosage may prove an effective measure in 
reducing the relapse rate in B.T. malaria and possibly 
ih the treatment of Quartan infections. 
7. ,A COMPARISON OF THE ACTION OF 
ANTI -MALARIAL DRUGS IN B.T. MALARIA. 
It is felt that a summary of the action of 
Quinine, Mepacriñe, Pamaquin and Paludrine in B.T. 
malaria, may usefully be given in tabular form and 
based on the findings recorded in this thesis. This 
is shown in Table 11 in which symbols are used to 
represent the relative intensity of effect under the 
various headings dealing with the main properties of 
anti -malarial drugs. 
8. SOME PRACTICAL CONSIDERATIONS 
IN B.T. MALARIA THERAPY. 
The rate of clearance of asexual parasites is 
a measure only of the rate of clinical cure. With 
the present -day drugs, this cure appears to be effect- 
ed in a time so short that little advantage would be 
gained by attempts to shorten it further. For 
instance, it has been shown that an extra rapid clear- 
ance of parasites occurs when Mepacrine is injected 
intramuscularly at a time when the parasites are most 
susceptible. This procedure, however, often causes 
so much clinical upset, that it is more of academic 
interest than of practical importance. Such measures 
would be justifiable only if they could be shown to 
alter the subsequent relapse rate. 
It/ 
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It has been seen that a rapid clinical cure of 
B.T. malaria can be brought about by the use of heavy 
oral Mepacrine or Paludrine. Accordingly it would 
seem logical to suggest that in areas where the chance 
of reinfection are high, treatment of this nature 
should be e?ployed during the infective season, rather 
than a therapy course designed to produce a high pro- 
portion of radical cures. The Mepacrine and Paludrin 
courses would have the additional advantages of being 
of short duration and of not interfering with the 
routine suppressive use of these drugs. 
On the other hand, when there is little risk 
of further infection, such as during the Winter months 
and when suppressive drugs are not in use, there is 
need for a more drastic attempt to eradicate those 
infections Which have bcome recurrent. A Quinine plus 
Pamaquin course is much more effective than Mepacrine 
or Paludrine in achieving this result and an inter- 
mittent dosage regime, such as reported in this thesis 
would appear to be worthy of consideration. It seems 
likely that combined Paludrine and Pamaquin therapy 
may soon be used rather than Quinine plus Pamaquin 
in the treatment of recurrent B.T. malaria and may 
produce still better results in the eradication of 
this "nuisance" condition. 
9./ 
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9. THE VALUE OF PARASITOLOGICAL STUDIES IN 
THE TRIAL OF ANTI -MALARIAL COMPOUNDS. 
Much of the work in this thesis is based on 
microscopical studies of malaria parasites during 
treatment with anti -malarial drugs, and attempts have 
been made to assess the therapeutic value and use of 
these compounds from the observations made. There 
are probably those who would consider that this 
microscopical approach has been given undue prominence 
in this work and that practical considerations, such 
as rate of reduction of pyrexia, should have received 
more attention as being of greater importance than 
the determination of the exact stage in the parasite 
asexual cycle on which the drug is most active. Such 
critics might also hold that studies such as the 
"Relapse Factor'T can have little bearing upon the 
problems of malaria chemotherapy; whereas in fact 
they shed valuable evidence on the influence of acquir 
ed immunity on the clinical manifestations and res.pons 
to treatment in B.T. infections. 
While it is agreed that the ultimate criteria 
on which the adoption of a new anti -malarial drug must 
rest, are its properties for benefitting the patient 
in the clinical sense, it is maintained that a detail- 
ed study of its effects on the causal parasite provide 
an essential spotlight on its mode of action with 
which most of its clinical effects can be correlated. 
As/ 
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As an example of how it is possible to forecast the 
value of such a 'drug from its parasitological action, 
it could be reasonably expected that Paludrine would 
produce no striking new cure of'B.T. malaria as soon 
as it was evident that its main effect on the parasite 
cycle was to attack the schizont stages in much the 
same manner as Quinine, Mepacrine and Pamaquin. No 
compound yet tried has been found to destroy specific- 
ally the growing trophozoites of B.T. malaria and it 
would indeed be interesting to observe the curative 
value of such a drug which might well be expected to 
produce a new form of therapy response in this condit- 
ion. 
In conclusion, therefore, a plea is entered . 
for the parasitologist and biochemist to join forces 
with the clinician so that together they may rational- 
ly demand from the synthetic chemist, new, calculated 
therapeutic compounds that will one day bring final 
victory over human malaria and write a new chapter 
in the history of chemotherapy. 
